Clin Exp Otorhinolaryngol.  2017 Mar;10(1):1-43. 10.21053/ceo.2016.01389.

Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery

• Korean Society of Thyroid-Head and Neck Surgery Guideline Task Force
• Ahn SH
• Hong HJ
• Kwon SY
• Kwon KH
• Roh JL
• Ryu J
• Park JH
• Baek SK
• Lee GH
• Lee SY
• Lee JC
• Chung MK
• Joo YH
• Ji YB
• Hah JH
• Kwon M
• Park YM
• Song CM
• Shin SC
• Ryu CH
• Lee DY
• Lee YC
• Chang JW
• Jeong HM
• Cho JK
• Cha W
• Chun BJ
• Choi IJ
• Choi HG
• Lee KD

• KMID: 2376406
• DOI: http://doi.org/10.21053/ceo.2016.01389

Abstract

Korean Society of Thyroid-Head and Neck Surgery appointed a Task Force to develop clinical practice guidelines for the surgical treatment of laryngeal cancer. This Task Force conducted a systematic search of the EMBASE, MEDLINE, Cochrane Library, and KoreaMed databases to identify relevant articles, using search terms selected according to the key questions. Evidence-based recommendations were then created on the basis of these articles. An external expert review and Delphi questionnaire were applied to reach consensus regarding the recommendations. The resulting guidelines focus on the surgical treatment of laryngeal cancer with the assumption that surgery is the selected treatment modality after a multidisciplinary discussion in any context. These guidelines do not, therefore, address non-surgical treatment such as radiation therapy or chemotherapy. The committee developed 62 evidence-based recommendations in 32 categories intended to assist clinicians during management of patients with laryngeal cancer and patients with laryngeal cancer, and counselors and health policy-makers.

Keyword

Laryngeal Neoplasms; Surgery; Practice Guideline; Glottis; Supraglottis

MeSH Terms

Advisory Committees
Consensus
Counseling
Drug Therapy
Glottis
Humans
Laryngeal Neoplasms*
Neck*

Reference

1. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; Jun. 324(24):1685–90.

2. Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med. 2003; Nov. 349(22):2091–8.

3. Kim SY, Park JE, Lee YJ, Seo HJ, Sheen SS, Hahn S, et al. Testing a tool for assessing the risk of bias for nonrandomized studies showed moderate reliability and promising validity. J Clin Epidemiol. 2013; Apr. 66(4):408–14.

4. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007; Feb. 7:10.

5. Qaseem A, Snow V, Owens DK, Shekelle P; Clinical Guidelines Committee of the American College of Physicians. The development of clinical practice guidelines and guidance statements of the American College of Physicians: summary of methods. Ann Intern Med. 2010; Aug. 153(3):194–9.

6. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, et al. Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest. 2006; Jan. 129(1):174–81.

7. Paul BC, Rafii B, Achlatis S, Amin MR, Branski RC. Morbidity and patient perception of flexible laryngoscopy. Ann Otol Rhinol Laryngol. 2012; Nov. 121(11):708–13.

8. Sataloff RT, Spiegel JR, Hawkshaw MJ. Strobovideolaryngoscopy: results and clinical value. Ann Otol Rhinol Laryngol. 1991; Sep. 100(9 Pt 1):725–7.

9. Casiano RR, Zaveri V, Lundy DS. Efficacy of videostroboscopy in the diagnosis of voice disorders. Otolaryngol Head Neck Surg. 1992; Jul. 107(1):95–100.

10. Paul BC, Chen S, Sridharan S, Fang Y, Amin MR, Branski RC. Diagnostic accuracy of history, laryngoscopy, and stroboscopy. Laryngoscope. 2013; Jan. 123(1):215–9.

11. El-Demerdash A, Fawaz SA, Sabri SM, Sweed A, Rabie H. Sensitivity and specificity of stroboscopy in preoperative differentiation of dysplasia from early invasive glottic carcinoma. Eur Arch Otorhinolaryngol. 2015; May. 272(5):1189–93.

12. Hawkshaw MJ, Sataloff JB, Sataloff RT. New concepts in vocal fold imaging: a review. J Voice. 2013; Nov. 27(6):738–43.

13. Cohen SM, Thomas S, Roy N, Kim J, Courey M. Frequency and factors associated with use of videolaryngostroboscopy in voice disorder assessment. Laryngoscope. 2014; Sep. 124(9):2118–24.

14. Bertino G, Cacciola S, Fernandes WB Jr, Fernandes CM, Occhini A, Tinelli C, et al. Effectiveness of narrow band imaging in the detection of premalignant and malignant lesions of the larynx: validation of a new endoscopic clinical classification. Head Neck. 2015; Feb. 37(2):215–22.

15. Crosetti E, Pilolli F, Succo G. A new strategy for endoscopic staging of laryngeal carcinoma: multistep endoscopy. Acta Otorhinolaryngol Ital. 2012; Jun. 32(3):175–81.

16. Hicks JN. Microlaryngology: an update on its modern use in laryngology: malignant early and advanced glottic carcinoma. Microsurgery. 1989; 10(4):321–4.

17. Kawaida M, Fukuda H, Kohno N. Digital image processing of laryngeal lesions by electronic videoendoscopy. Laryngoscope. 2002; Mar. 112(3):559–64.

18. Thabet HM, Sessions DG, Gado MH, Gnepp DA, Harvey JE, Talaat M. Comparison of clinical evaluation and computed tomographic diagnostic accuracy for tumors of the larynx and hypopharynx. Laryngoscope. 1996; May. 106(5 Pt 1):589–94.

19. Zbaren P, Becker M, Lang H. Pretherapeutic staging of laryngeal carcinoma: clinical findings, computed tomography, and magnetic resonance imaging compared with histopathology. Cancer. 1996; Apr. 77(7):1263–73.

20. Loevner LA, Yousem DM, Montone KT, Weber R, Chalian AA, Weinstein GS. Can radiologists accurately predict preepiglottic space invasion with MR imaging. AJR Am J Roentgenol. 1997; Dec. 169(6):1681–7.

21. Zbaren P, Becker M, Lang H. Pretherapeutic staging of hypopharyngeal carcinoma. Clinical findings, computed tomography, and magnetic resonance imaging compared with histopathologic evaluation. Arch Otolaryngol Head Neck Surg. 1997; Sep. 123(9):908–13.

22. Banko B, Djukic V, Milovanovic J, Kovac J, Novakovic Z, Maksimovic R. MRI in evaluation of neoplastic invasion into preepiglottic and paraglottic space. Auris Nasus Larynx. 2014; Oct. 41(5):471–4.

23. Banko B, Dukic V, Milovanovic J, Kovac JD, Artiko V, Maksimovic R. Diagnostic significance of magnetic resonance imaging in preoperative evaluation of patients with laryngeal tumors. Eur Arch Otorhinolaryngol. 2011; Nov. 268(11):1617–23.

24. Huang BY, Solle M, Weissler MC. Larynx: anatomic imaging for diagnosis and management. Otolaryngol Clin North Am. 2012; Dec. 45(6):1325–61.

25. Kelsch TA, Patel U. Partial laryngectomy imaging. Semin Ultrasound CT MR. 2003; Jun. 24(3):147–56.

26. Castelijns JA, Hermans R, van den Brekel MW, Mukherji SK. Imaging of laryngeal cancer. Semin Ultrasound CT MR. 1998; Dec. 19(6):492–504.

27. Becker M, Zbaren P, Delavelle J, Kurt AM, Egger C, Rufenacht DA, et al. Neoplastic invasion of the laryngeal cartilage: reassessment of criteria for diagnosis at CT. Radiology. 1997; May. 203(2):521–32.

28. Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, et al. Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol. 2010; May. 28(14):2318–22.

29. Xia CX, Zhu Q, Zhao HX, Yan F, Li SL, Zhang SM. Usefulness of ultrasonography in assessment of laryngeal carcinoma. Br J Radiol. 2013; Oct. 86(1030):20130343.

30. Adolphs AP, Boersma NA, Diemel BD, Eding JE, Flokstra FE, Wegner I, et al. A systematic review of computed tomography detection of cartilage invasion in laryngeal carcinoma. Laryngoscope. 2015; Jul. 125(7):1650–5.

31. Zinreich SJ. Imaging in laryngeal cancer: computed tomography, magnetic resonance imaging, positron emission tomography. Otolaryngol Clin North Am. 2002; Oct. 35(5):971–91.

32. Taha MS, Hassan O, Amir M, Taha T, Riad MA. Diffusion-weighted MRI in diagnosing thyroid cartilage invasion in laryngeal carcinoma. Eur Arch Otorhinolaryngol. 2014; Sep. 271(9):2511–6.

33. Becker M, Zbaren P, Laeng H, Stoupis C, Porcellini B, Vock P. Neoplastic invasion of the laryngeal cartilage: comparison of MR imaging and CT with histopathologic correlation. Radiology. 1995; Mar. 194(3):661–9.

34. Becker M. Neoplastic invasion of laryngeal cartilage: radiologic diagnosis and therapeutic implications. Eur J Radiol. 2000; Mar. 33(3):216–29.

35. Peters TT, Castelijns JA, Ljumanovic R, Witte BI, Leemans CR, de Bree R. Diagnostic value of CT and MRI in the detection of paratracheal lymph node metastasis. Oral Oncol. 2012; May. 48(5):450–5.

36. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: head and neck cancers, version 1, 2015 [Internet]. Fort Washington: National Comprehensive Cancer Network;c2016. [cited 2016 Oct 28]. Available from: https://www.nccn.org.

37. Wissinger E, Griebsch I, Lungershausen J, Foster T, Pashos CL. The economic burden of head and neck cancer: a systematic literature review. Pharmacoeconomics. 2014; Sep. 32(9):865–82.

38. Lowe VJ, Kim H, Boyd JH, Eisenbeis JF, Dunphy FR, Fletcher JW. Primary and recurrent early stage laryngeal cancer: preliminary results of 2-[fluorine 18]fluoro-2-deoxy-D-glucose PET imaging. Radiology. 1999; Sep. 212(3):799–802.

39. Blitz AM, Aygun N. Radiologic evaluation of larynx cancer. Otolaryngol Clin North Am. 2008; Aug. 41(4):697–713.

40. Jeong HS, Chung MK, Baek CH, Choi JY, Son YI, Kim HJ, et al. Combined 18F-FDG PET/CT imaging for the initial evaluation of glottic cancer. Clin Exp Otorhinolaryngol. 2008; Mar. 1(1):35–40.

41. Sun R, Tang X, Yang Y, Zhang C. (18)FDG-PET/CT for the detection of regional nodal metastasis in patients with head and neck cancer: a meta-analysis. Oral Oncol. 2015; Apr. 51(4):314–20.

42. Rohde M, Dyrvig AK, Johansen J, Sorensen JA, Gerke O, Nielsen AL, et al. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis. Eur J Cancer. 2014; Sep. 50(13):2271–9.

43. Kyzas PA, Evangelou E, Denaxa-Kyza D, Ioannidis JP. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst. 2008; May. 100(10):712–20.

44. Roh JL, Park JP, Kim JS, Lee JH, Cho KJ, Choi SH, et al. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study. Radiology. 2014; Apr. 271(1):153–61.

45. Kim SY, Roh JL, Yeo NK, Kim JS, Lee JH, Choi SH, et al. Combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer. Ann Oncol. 2007; Oct. 18(10):1698–703.

46. Xu GZ, Guan DJ, He ZY. (18)FDG-PET/CT for detecting distant metastases and second primary cancers in patients with head and neck cancer: a meta-analysis. Oral Oncol. 2011; Jul. 47(7):560–5.

47. Hanamoto A, Takenaka Y, Shimosegawa E, Ymamamoto Y, Yoshii T, Nakahara S, et al. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. Ann Nucl Med. 2013; Dec. 27(10):880–5.

48. Kanda T, Kitajima K, Suenaga Y, Konishi J, Sasaki R, Morimoto K, et al. Value of retrospective image fusion of 18F-FDG PET and MRI for preoperative staging of head and neck cancer: comparison with PET/CT and contrast-enhanced neck MRI. Eur J Radiol. 2013; Nov. 82(11):2005–10.

49. Tamura E, Kitahara S, Kohno N. Clinical assessment of intralaryngeal ultrasonography. Laryngoscope. 2001; Oct. 111(10):1767–70.

50. Kau RJ, Alexiou C, Stimmer H, Arnold W. Diagnostic procedures for detection of lymph node metastases in cancer of the larynx. ORL J Otorhinolaryngol Relat Spec. 2000; Jul-Aug. 62(4):199–203.

51. Desai AA, Pandya VK, Bhalani DB, Desai S, Parikh BD. Value of ultrasonography in laryngeal and laryngopharyngeal cancers. Indian J Otolaryngol Head Neck Surg. 2004; Jul. 56(3):191–5.

52. Kuribayashi S, Miyashita T, Nakamizo M, Yagi T, Kumita S. Utility of sonography for evaluation of clinical T1 and T2 glottic carcinoma. J Ultrasound Med. 2009; Nov. 28(11):1429–40.

53. Hu Q, Zhu SY, Zhang Z, Luo F, Mao YP, Guan XH. Assessment of glottic squamous cell carcinoma: comparison of sonography and non-contrast-enhanced magnetic resonance imaging. J Ultrasound Med. 2011; Nov. 30(11):1467–74.

54. Klotz HP, Candinas D, Platz A, Horvath A, Dindo D, Schlumpf R, et al. Preoperative risk assessment in elective general surgery. Br J Surg. 1996; Dec. 83(12):1788–91.

55. Fleisher LA, Fleischmann KE, Auerbach AD, Barnason SA, Beckman JA, Bozkurt B, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; Dec. 130(24):e278–333.

56. Partridge JS, Harari D, Martin FC, Dhesi JK. The impact of pre-operative comprehensive geriatric assessment on postoperative outcomes in older patients undergoing scheduled surgery: a systematic review. Anaesthesia. 2014; Jan. 69 Suppl 1:8–16.

57. Chu EA, Kim YJ. Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am. 2008; Aug. 41(4):673–95.

58. Licker M, Schweizer A, Ellenberger C, Tschopp JM, Diaper J, Clergue F. Perioperative medical management of patients with COPD. Int J Chron Obstruct Pulmon Dis. 2007; Jan. 2(4):493–515.

59. Joo YH, Sun DI, Cho JH, Cho KJ, Kim MS. Factors that predict postoperative pulmonary complications after supracricoid partial laryngectomy. Arch Otolaryngol Head Neck Surg. 2009; Nov. 135(11):1154–7.

60. Chow JM, Block RM, Friedman M. Preoperative evaluation for partial laryngectomy. Head Neck Surg. 1988; May-Jun. 10(5):319–23.

61. Atienza JA, Dasanu CA. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin. 2012; Dec. 28(12):1899–909.

62. Schwartz LH, Ozsahin M, Zhang GN, Touboul E, De Vataire F, Andolenko P, et al. Synchronous and metachronous head and neck carcinomas. Cancer. 1994; Oct. 74(7):1933–8.

63. Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A. Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev. 2006; Nov. 32(7):504–15.

64. Stoeckli SJ, Steinert H, Pfaltz M, Schmid S. Is there a role for positron emission tomography with 18F-fluorodeoxyglucose in the initial staging of nodal negative oral and oropharyngeal squamous cell carcinoma. Head Neck. 2002; Apr. 24(4):345–9.

65. Strobel K, Haerle SK, Stoeckli SJ, Schrank M, Soyka JD, Veit-Haibach P, et al. Head and neck squamous cell carcinoma (HNSCC): detection of synchronous primaries with (18)F-FDG-PET/CT. Eur J Nucl Med Mol Imaging. 2009; Jun. 36(6):919–27.

66. Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR Am J Roentgenol. 2004; May. 182(5):1129–32.

67. Shaha AR, Hoover EL, Mitrani M, Marti JR, Krespi YP. Synchronicity, multicentricity, and metachronicity of head and neck cancer. Head Neck Surg. 1988; Mar-Apr. 10(4):225–8.

68. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol. 1992; Feb. 101(2 Pt 1):105–12.

69. Sadri M, McMahon J, Parker A. Laryngeal dysplasia: aetiology and molecular biology. J Laryngol Otol. 2006; Mar. 120(3):170–7.

70. Brugere J, Guenel P, Leclerc A, Rodriguez J. Differential effects of tobacco and alcohol in cancer of the larynx, pharynx, and mouth. Cancer. 1986; Jan. 57(2):391–5.

71. Simo R, Bradley P, Chevalier D, Dikkers F, Eckel H, Matar N, et al. European Laryngological Society: ELS recommendations for the follow-up of patients treated for laryngeal cancer. Eur Arch Otorhinolaryngol. 2014; Sep. 271(9):2469–79.

72. International Agency for Research on Cancer. European cancer observatory [Internet]. Lyon: World Health Organization;c2012. [cited 2016 Oct 28]. Available from: http://eu-cancer.iarc.fr.

73. National Cancer Institute at the National Institutes of Health. Laryngeal cancer treatment (PDQ®): patient version [Internet]. Bethesda: National Cancer Institute;2015. [cited 2016 Oct 28]. Available from: http://www.cancer.gov/types/head-and-neck/patient/laryngeal-treatment-pdq.

74. Talamini R, Bosetti C, La Vecchia C, Dal Maso L, Levi F, Bidoli E, et al. Combined effect of tobacco and alcohol on laryngeal cancer risk: a case-control study. Cancer Causes Control. 2002; Dec. 13(10):957–64.

75. Tuyns AJ, Esteve J, Raymond L, Berrino F, Benhamou E, Blanchet F, et al. Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer. 1988; Apr. 41(4):483–91.

76. Bosetti C, Garavello W, Gallus S, La Vecchia C. Effects of smoking cessation on the risk of laryngeal cancer: an overview of published studies. Oral Oncol. 2006; Oct. 42(9):866–72.

77. Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F, Bouvard V, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol. 2007; Apr. 8(4):292–3.

78. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010; Mar. 46(4):765–81.

79. Graham S, Mettlin C, Marshall J, Priore R, Rzepka T, Shedd D. Dietary factors in the epidemiology of cancer of the larynx. Am J Epidemiol. 1981; Jun. 113(6):675–80.

80. Hellquist H, Lundgren J, Olofsson J. Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords: a follow-up study. Clin Otolaryngol Allied Sci. 1982; Feb. 7(1):11–27.

81. Muscat JE, Wynder EL. Tobacco, alcohol, asbestos, and occupational risk factors for laryngeal cancer. Cancer. 1992; May. 69(9):2244–51.

82. El-Serag HB, Hepworth EJ, Lee P, Sonnenberg A. Gastroesophageal reflux disease is a risk factor for laryngeal and pharyngeal cancer. Am J Gastroenterol. 2001; Jul. 96(7):2013–8.

83. Coca-Pelaz A, Rodrigo JP, Takes RP, Silver CE, Paccagnella D, Rinaldo A, et al. Relationship between reflux and laryngeal cancer. Head Neck. 2013; Dec. 35(12):1814–8.

84. Capone RB, Pai SI, Koch WM, Gillison ML, Danish HN, Westra WH, et al. Detection and quantitation of human papillomavirus (HPV) DNA in the sera of patients with HPV-associated head and neck squamous cell carcinoma. Clin Cancer Res. 2000; Nov. 6(11):4171–5.

85. Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000; May. 92(9):709–20.

86. Fleskens SA, van der Laak JA, Slootweg PJ, Takes RP. Management of laryngeal premalignant lesions in the Netherlands. Laryngoscope. 2010; Jul. 120(7):1326–35.

87. Ferlito A, Devaney KO, Woolgar JA, Slootweg PJ, Paleri V, Takes RP, et al. Squamous epithelial changes of the larynx: diagnosis and therapy. Head Neck. 2012; Dec. 34(12):1810–6.

88. Colden D, Zeitels SM, Hillman RE, Jarboe J, Bunting G, Spanou K. Stroboscopic assessment of vocal fold keratosis and glottic cancer. Ann Otol Rhinol Laryngol. 2001; Apr. 110(4):293–8.

89. Mehlmann M, Betz CS, Stepp H, Arbogast S, Baumgartner R, Grevers G, et al. Fluorescence staining of laryngeal neoplasms after topical application of 5-aminolevulinic acid: preliminary results. Lasers Surg Med. 1999; Dec. 25(5):414–20.

90. Lundgren J, Olofsson J, Hellquist H. Toluidine blue. An aid in the microlaryngoscopic diagnosis of glottic lesions. Arch Otolaryngol. 1979; Apr. 105(4):169–74.

91. Andrea M, Dias O, Santos A. Contact endoscopy of the vocal cord: normal and pathological patterns. Acta Otolaryngol. 1995; Mar. 115(2):314–6.

92. Malzahn K, Dreyer T, Glanz H, Arens C. Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesions. Laryngoscope. 2002; Mar. 112(3):488–93.

93. Armstrong WB, Ridgway JM, Vokes DE, Guo S, Perez J, Jackson RP, et al. Optical coherence tomography of laryngeal cancer. Laryngoscope. 2006; Jul. 116(7):1107–13.

94. Ni XG, He S, Xu ZG, Gao L, Lu N, Yuan Z, et al. Endoscopic diagnosis of laryngeal cancer and precancerous lesions by narrow band imaging. J Laryngol Otol. 2011; Mar. 125(3):288–96.

95. Delank W, Khanavkar B, Nakhosteen JA, Stoll W. A pilot study of autofluorescent endoscopy for the in vivo detection of laryngeal cancer. Laryngoscope. 2000; Mar. 110(3 Pt 1):368–73.

96. Arens C, Reussner D, Woenkhaus J, Leunig A, Betz CS, Glanz H. Indirect fluorescence laryngoscopy in the diagnosis of precancerous and cancerous laryngeal lesions. Eur Arch Otorhinolaryngol. 2007; Jun. 264(6):621–6.

97. Zargi M, Fajdiga I, Smid L. Autofluorescence imaging in the diagnosis of laryngeal cancer. Eur Arch Otorhinolaryngol. 2000; 257(1):17–23.

98. Sadri M, McMahon J, Parker A. Management of laryngeal dysplasia: a review. Eur Arch Otorhinolaryngol. 2006; Sep. 263(9):843–52.

99. Plch J, Par I, Navratilova I, Blahova M, Zavadil M. Long term follow-up study of laryngeal precancer. Auris Nasus Larynx. 1998; Dec. 25(4):407–12.

100. Hintz BL, Kagan AR, Nussbaum H, Rao AR, Chan PY, Miles J. A ‘watchful waiting’ policy for in situ carcinoma of the vocal cords. Arch Otolaryngol. 1981; Dec. 107(12):746–51.

101. Miller AH, Fisher HR. Clues to the life history of carcinoma in situ of the larynx. Laryngoscope. 1971; Sep. 81(9):1475–80.

102. Stenersen TC, Hoel PS, Boysen M. Carcinoma in situ of the larynx: results with different methods of treatment. Acta Otolaryngol Suppl. 1988; 449:131–3.

103. Stenersen TC, Hoel PS, Boysen M. Carcinoma in situ of the larynx: an evaluation of its natural clinical course. Clin Otolaryngol Allied Sci. 1991; Aug. 16(4):358–63.

104. Sllamniku B, Bauer W, Painter C, Sessions D. The transformation of laryngeal keratosis into invasive carcinoma. Am J Otolaryngol. 1989; Jan-Feb. 10(1):42–54.

105. Blackwell KE, Calcaterra TC, Fu YS. Laryngeal dysplasia: epidemiology and treatment outcome. Ann Otol Rhinol Laryngol. 1995; Aug. 104(8):596–602.

106. Paleri V, Mackenzie K, Wight RG, Mehanna H, Pracy P, Bradley PJ, et al. Management of laryngeal dysplasia in the United Kingdom: a web-based questionnaire survey of current practice. Clin Otolaryngol. 2009; Aug. 34(4):385–9.

107. Mehanna H, Paleri V, Robson A, Wight R, Helliwell T. Consensus statement by otorhinolaryngologists and pathologists on the diagnosis and management of laryngeal dysplasia. Clin Otolaryngol. 2010; Jun. 35(3):170–6.

108. Csanady M, Czigner J, Savay L. Endolaryngeal CO2 laser microsurgery of early vocal cord cancer. A retrospective study. Adv Otorhinolaryngol. 1995; 49:219–21.

109. Eckel HE. Local recurrences following transoral laser surgery for early glottic carcinoma: frequency, management, and outcome. Ann Otol Rhinol Laryngol. 2001; Jan. 110(1):7–15.

110. Mendenhall WM, Werning JW, Hinerman RW, Amdur RJ, Villaret DB. Management of T1-T2 glottic carcinomas. Cancer. 2004; May. 100(9):1786–92.

111. Motta G, Esposito E, Cassiano B, Motta S. T1-T2-T3 glottic tumors: fifteen years experience with CO2 laser. Acta Otolaryngol Suppl. 1997; 527:155–9.

112. Ossoff RH, Sisson GA, Shapshay SM. Endoscopic management of selected early vocal cord carcinoma. Ann Otol Rhinol Laryngol. 1985; Nov-Dec. 94(6 Pt 1):560–4.

113. Steiner W. Results of curative laser microsurgery of laryngeal carcinomas. Am J Otolaryngol. 1993; Mar-Apr. 14(2):116–21.

114. Wolfensberger M, Dort JC. Endoscopic laser surgery for early glottis carcinoma: a clinical and experimental study. Laryngoscope. 1990; Oct. 100(10 Pt 1):1100–5.

115. Remacle F, Nest M, Levine RD. Laser steered ultrafast quantum dynamics of electrons in LiH. Phys Rev Lett. 2007; Nov. 99(18):183902.

116. Silver CE, Beitler JJ, Shaha AR, Rinaldo A, Ferlito A. Current trends in initial management of laryngeal cancer: the declining use of open surgery. Eur Arch Otorhinolaryngol. 2009; Sep. 266(9):1333–52.

117. Higgins KM. What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility. Laryngoscope. 2011; Jan. 121(1):116–34.

118. Hartl DM, de Mones E, Hans S, Janot F, Brasnu D. Treatment of early-stage glottic cancer by transoral laser resection. Ann Otol Rhinol Laryngol. 2007; Nov. 116(11):832–6.

119. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for untreated glottic carcinoma. Otolaryngol Head Neck Surg. 2007; Sep. 137(3):482–6.

120. Sjogren EV, Langeveld TP, Baatenburg de Jong RJ. Clinical outcome of T1 glottic carcinoma since the introduction of endoscopic CO2 laser surgery as treatment option. Head Neck. 2008; Sep. 30(9):1167–74.

121. Bradley PJ, Mackenzie K, Wight R, Pracy P, Paleri V; ENT-UK Head & Neck Group. Consensus statement on management in the UK: transoral laser assisted microsurgical resection of early glottic cancer. Clin Otolaryngol. 2009; Aug. 34(4):367–73.

122. McGuirt WF, Blalock D, Koufman JA, Feehs RS, Hilliard AJ, Greven K, et al. Comparative voice results after laser resection or irradiation of T1 vocal cord carcinoma. Arch Otolaryngol Head Neck Surg. 1994; Sep. 120(9):951–5.

123. Peretti G, Piazza C, Cocco D, De Benedetto L, Del Bon F, Redaelli De Zinis LO, et al. Transoral CO(2) laser treatment for T(is)-T(3) glottic cancer: the University of Brescia experience on 595 patients. Head Neck. 2010; Aug. 32(8):977–83.

124. Rodel RM, Steiner W, Muller RM, Kron M, Matthias C. Endoscopic laser surgery of early glottic cancer: involvement of the anterior commissure. Head Neck. 2009; May. 31(5):583–92.

125. Ogura JH. Selection of patients for conservation surgery of the larynx and pharynx. Trans Am Acad Ophthalmol Otolaryngol. 1972; May-Jun. 76(3):741–51.

126. Gallo A, de Vincentiis M, Manciocco V, Simonelli M, Fiorella ML, Shah JP. CO2 laser cordectomy for early-stage glottic carcinoma: a long-term follow-up of 156 cases. Laryngoscope. 2002; Feb. 112(2):370–4.

127. Sigston E, de Mones E, Babin E, Hans S, Hartl DM, Clement P, et al. Early-stage glottic cancer: oncological results and margins in laser cordectomy. Arch Otolaryngol Head Neck Surg. 2006; Feb. 132(2):147–52.

128. Liu C, Ward PH, Pleet L. Imbrication reconstruction following partial laryngectomy. Ann Otol Rhinol Laryngol. 1986; Nov-Dec. 95(6 Pt 1):567–71.

129. Bailey BJ, Calcaterra TC. Vertical, subtotal laryngectomy and laryngoplasty: review of experience. Arch Otolaryngol. 1971; Mar. 93(3):232–7.

130. Laccourreye O, Weinstein G, Brasnu D, Trotoux J, Laccourreye H. Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol. 1991; Jan. 100(1):68–71.

131. Johnson JT, Myers EN, Hao SP, Wagner RL. Outcome of open surgical therapy for glottic carcinoma. Ann Otol Rhinol Laryngol. 1993; Oct. 102(10):752–5.

132. Laccourreye O, Muscatello L, Laccourreye L, Naudo P, Brasnu D, Weinstein G. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for “early” glottic carcinoma classified as T1-T2N0 invading the anterior commissure. Am J Otolaryngol. 1997; Nov-Dec. 18(6):385–90.

133. Laudadio P, Presutti L, Dall’olio D, Cunsolo E, Consalici R, Amorosa L, et al. Supracricoid laryngectomies: long-term oncological and functional results. Acta Otolaryngol. 2006; Jun. 126(6):640–9.

134. Lima RA, Freitas EQ, Kligerman J, Dias FL, Barbosa MM, Sa GM, et al. Supracricoid laryngectomy with CHEP: functional results and outcome. Otolaryngol Head Neck Surg. 2001; Mar. 124(3):258–60.

135. Lima RA, Freitas EQ, Dias FL, Barbosa MM, Kligerman J, Soares JR, et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy for advanced glottic cancer. Head Neck. 2006; Jun. 28(6):481–6.

136. Nakayama M, Okamoto M, Miyamoto S, Takeda M, Yokobori S, Masaki T, et al. Supracricoid laryngectomy with cricohyoidoepiglotto-pexy or cricohyoido-pexy: experience on 32 patients. Auris Nasus Larynx. 2008; Mar. 35(1):77–82.

137. Mercante G, Grammatica A, Battaglia P, Cristalli G, Pellini R, Spriano G. Supracricoid partial laryngectomy in the management of t3 laryngeal cancer. Otolaryngol Head Neck Surg. 2013; Nov. 149(5):714–20.

138. Page C, Mortuaire G, Mouawad F, Ganry O, Darras J, Pasquesoone X, et al. Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results: a 35-year experience. Eur Arch Otorhinolaryngol. 2013; May. 270(6):1927–32.

139. Thomas L, Drinnan M, Natesh B, Mehanna H, Jones T, Paleri V. Open conservation partial laryngectomy for laryngeal cancer: a systematic review of English language literature. Cancer Treat Rev. 2012; May. 38(3):203–11.

140. American Society of Clinical Oncology, Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, et al. American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol. 2006; Aug. 24(22):3693–704.

141. Broyles E. The rotating anterior commissure laryngoscope. Trans Annu Meet Am Bronchoesophagol Assoc. 1952; 53(32nd Meeting):22.

142. Bagatella F, Bignardi L. Morphological study of the laryngeal anterior commissure with regard to the spread of cancer. Acta Otolaryngol. 1981; Jul-Aug. 92(1-2):167–71.

143. Kirchner JA, Carter D. Intralaryngeal barriers to the spread of cancer. Acta Otolaryngol. 1987; May-Jun. 103(5-6):503–13.

144. Shvero J, Hadar T, Segal K, Yaniv E, Marshak G, Feinmesser R. T1 glottic carcinoma involving the anterior commissure. Eur J Surg Oncol. 1994; Oct. 20(5):557–60.

145. Rucci L, Gammarota L, Borghi Cirri MB. Carcinoma of the anterior commissure of the larynx. I. Embryological and anatomic considerations. Ann Otol Rhinol Laryngol. 1996; Apr. 105(4):303–8.

146. Brandenburg JH, Condon KG, Frank TW. Coronal sections of larynges from radiation-therapy failures: a clinical-pathologic study. Otolaryngol Head Neck Surg. 1986; Sep. 95(2):213–8.

147. Chone CT, Yonehara E, Martins JE, Altemani A, Crespo AN. Importance of anterior commissure in recurrence of early glottic cancer after laser endoscopic resection. Arch Otolaryngol Head Neck Surg. 2007; Sep. 133(9):882–7.

148. Steiner W, Ambrosch P, Rodel RM, Kron M. Impact of anterior commissure involvement on local control of early glottic carcinoma treated by laser microresection. Laryngoscope. 2004; Aug. 114(8):1485–91.

149. Krespi YP, Meltzer CJ. Laser surgery for vocal cord carcinoma involving the anterior commissure. Ann Otol Rhinol Laryngol. 1989; Feb. 98(2):105–9.

150. Strong MS. Laser excision of carcinoma of the larynx. Laryngoscope. 1975; Aug. 85(8):1286–9.

151. Pillsbury HC 3rd, Clark M. A rationale for therapy of the N0 neck. Laryngoscope. 1997; Oct. 107(10):1294–315.

152. Koufman JA. The endoscopic management of early squamous carcinoma of the vocal cord with the carbon dioxide surgical laser: clinical experience and a proposed subclassification. Otolaryngol Head Neck Surg. 1986; Dec. 95(5):531–7.

153. Desloge RB, Zeitels SM. Endolaryngeal microsurgery at the anterior glottal commissure: controversies and observations. Ann Otol Rhinol Laryngol. 2000; Apr. 109(4):385–92.

154. Pearson BW, Salassa JR. Transoral laser microresection for cancer of the larynx involving the anterior commissure. Laryngoscope. 2003; Jul. 113(7):1104–12.

155. Peretti G, Nicolai P, Piazza C, Redaelli de Zinis LO, Valentini S, Antonelli AR. Oncological results of endoscopic resections of Tis and T1 glottic carcinomas by carbon dioxide laser. Ann Otol Rhinol Laryngol. 2001; Sep. 110(9):820–6.

156. Pradhan SA, Pai PS, Neeli SI, D’Cruz AK. Transoral laser surgery for early glottic cancers. Arch Otolaryngol Head Neck Surg. 2003; Jun. 129(6):623–5.

157. Crampette L, Garrel R, Gardiner Q, Maurice N, Mondain M, Makeieff M, et al. Modified subtotal laryngectomy with cricohyoidoepiglottopexy: long term results in 81 patients. Head Neck. 1999; Mar. 21(2):95–103.

158. Spector JG, Sessions DG, Chao KS, Haughey BH, Hanson JM, Simpson JR, et al. Stage I (T1 N0 M0) squamous cell carcinoma of the laryngeal glottis: therapeutic results and voice preservation. Head Neck. 1999; Dec. 21(8):707–17.

159. Spector JG, Sessions DG, Chao KS, Hanson JM, Simpson JR, Perez CA. Management of stage II (T2N0M0) glottic carcinoma by radiotherapy and conservation surgery. Head Neck. 1999; Mar. 21(2):116–23.

160. Brumund KT, Gutierrez-Fonseca R, Garcia D, Babin E, Hans S, Laccourreye O. Frontolateral vertical partial laryngecomty without tracheostomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol. 2005; Apr. 114(4):314–22.

161. Bakhos D, Lescanne E, Beutter P, Moriniere S. Indications of cricohyoidoepiglottopexy versus anterior frontal laryngectomy: the role of contralateral vocal fold spread. Head Neck. 2008; Nov. 30(11):1408–14.

162. Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W. Results of 226 patients with T3 laryngeal carcinoma after treatment with transoral laser microsurgery. Head Neck. 2014; May. 36(5):652–9.

163. Canis M, Ihler F, Martin A, Wolff HA, Matthias C, Steiner W. Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option? Eur Arch Otorhinolaryngol. 2013; Sep. 270(10):2719–27.

164. Foote RL, Olsen KD, Buskirk SJ, Stanley RJ, Suman VJ. Laryngectomy alone for T3 glottic cancer. Head Neck. 1994; Sep-Oct. 16(5):406–12.

165. Razack MS, Maipang T, Sako K, Bakamjian V, Shedd DP. Management of advanced glottic carcinomas. Am J Surg. 1989; Oct. 158(4):318–20.

166. Sessions DG, Lenox J, Spector GJ, Newland D, Simpson J, Haughey BH, et al. Management of T3N0M0 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2002; Jul. 112(7 Pt 1):1281–8.

167. Biller HF, Lawson W. Partial laryngectomy for vocal cord cancer with marked limitation or fixation of the vocal cord. Laryngoscope. 1986; Jan. 96(1):61–4.

168. Lesinski SG, Bauer WC, Ogura JH. Hemilaryngectomy for T3 (fixed cord) epidermoid carcinoma of larynx. Laryngoscope. 1976; Oct. 86(10):1563–71.

169. Vega SF, Scola B, Vega MF, Martinez T, Scola E. Laryngeal vertical partial surgery. Surgical techniques. Oncological and functional results. Acta Otorhinolaryngol Ital. 1996; Jun. 16(3):272–80.

170. Chevalier D, Laccourreye O, Brasnu D, Laccourreye H, Piquet JJ. Cricohyoidoepiglottopexy for glottic carcinoma with fixation or impaired motion of the true vocal cord: 5-year oncologic results with 112 patients. Ann Otol Rhinol Laryngol. 1997; May. 106(5):364–9.

171. Piquet JJ, Chevalier D. Subtotal laryngectomy with crico-hyoidoepiglotto-pexy for the treatment of extended glottic carcinomas. Am J Surg. 1991; Oct. 162(4):357–61.

172. Laccourreye O, Laccourreye L, Muscatello L, Perie S, Weinstein G, Brasnu D. Local failure after supracricoid partial laryngectomy: symptoms, management, and outcome. Laryngoscope. 1998; Mar. 108(3):339–44.

173. Vilaseca I, Bernal-Sprekelsen M. Transoral laser microsurgery for locally advanced laryngeal cancer. Acta Otorrinolaringol Esp. 2013; Mar-Apr. 64(2):140–9.

174. Wang Y, Li X, Pan Z. Analyses of functional and oncologic outcomes following supracricoid partial laryngectomy. Eur Arch Otorhinolaryngol. 2015; Nov. 272(11):3463–8.

175. Weinstein GS, Laccourreye O, Ruiz C, Dooley P, Chalian A, Mirza N. Larynx preservation with supracricoid partial laryngectomy with cricohyoidoepiglottopexy: correlation of videostroboscopic findings and voice parameters. Ann Otol Rhinol Laryngol. 2002; Jan. 111(1):1–7.

176. Benito J, Holsinger FC, Perez-Martin A, Garcia D, Weinstein GS, Laccourreye O. Aspiration after supracricoid partial laryngectomy: incidence, risk factors, management, and outcomes. Head Neck. 2011; May. 33(5):679–85.

177. Dufour X, Hans S, De Mones E, Brasnu D, Menard M, Laccourreye O. Local control after supracricoid partial laryngectomy for “advanced” endolaryngeal squamous cell carcinoma classified as T3. Arch Otolaryngol Head Neck Surg. 2004; Sep. 130(9):1092–9.

178. Naudo P, Laccourreye O, Weinstein G, Hans S, Laccourreye H, Brasnu D. Functional outcome and prognosis factors after supracricoid partial laryngectomy with cricohyoidopexy. Ann Otol Rhinol Laryngol. 1997; Apr. 106(4):291–6.

179. Targa L, Grandi E, Chiarello G, Farina A, Carinci F, Merlo R, et al. Prognostic evaluation in supracricoid partial laryngectomy with cricohyoidopexy. Eur Arch Otorhinolaryngol. 2005; Jun. 262(6):465–9.

180. Sun DI, Cho KJ, Cho JH, Joo YH, Jung CK, Kim MS. Pathological validation of supracricoid partial laryngectomy in laryngeal cancer. Clin Otolaryngol. 2009; Apr. 34(2):132–9.

181. Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013; Mar. 31(7):845–52.

182. Kumar R, Drinnan M, Robinson M, Meikle D, Stafford F, Welch A, et al. Thyroid gland invasion in total laryngectomy and total laryngopharyngectomy: a systematic review and meta-analysis of the English literature. Clin Otolaryngol. 2013; Oct. 38(5):372–8.

183. Mendelson AA, Al-Khatib TA, Julien M, Payne RJ, Black MJ, Hier MP. Thyroid gland management in total laryngectomy: meta-analysis and surgical recommendations. Otolaryngol Head Neck Surg. 2009; Mar. 140(3):298–305.

184. Ferlito A, Rinaldo A, Silver CE, Robbins KT, Medina JE, Rodrigo JP, et al. Neck dissection for laryngeal cancer. J Am Coll Surg. 2008; Oct. 207(4):587–93.

185. Yu WB, Zeng ZY, Chen FJ, Zhang Q, Guo ZM, Li H, et al. Correlation of cervical lymphatic metastasis to prognosis of T3-T4 glottic cancer. Ai Zheng. 2006; Oct. 25(10):1271–4.

186. dos Santos CR, Goncalves Filho J, Magrin J, Johnson LF, Ferlito A, Kowalski LP. Involvement of level I neck lymph nodes in advanced squamous carcinoma of the larynx. Ann Otol Rhinol Laryngol. 2001; Oct. 110(10):982–4.

187. Lohuis PJ, Klop WM, Tan IB, van Den Brekel MW, Hilgers FJ, Balm AJ. Effectiveness of therapeutic (N1, N2) selective neck dissection (levels II to V) in patients with laryngeal and hypopharyngeal squamous cell carcinoma. Am J Surg. 2004; Feb. 187(2):295–9.

188. Candela FC, Shah J, Jaques DP, Shah JP. Patterns of cervical node metastases from squamous carcinoma of the larynx. Arch Otolaryngol Head Neck Surg. 1990; Apr. 116(4):432–5.

189. Davidson BJ, Kulkarny V, Delacure MD, Shah JP. Posterior triangle metastases of squamous cell carcinoma of the upper aerodigestive tract. Am J Surg. 1993; Oct. 166(4):395–8.

190. Medina JE, Ferlito A, Robbins KT, Silver CE, Rodrigo JP, de Bree R, et al. Central compartment dissection in laryngeal cancer. Head Neck. 2011; May. 33(5):746–52.

191. Amar A, Chedid HM, Franzi SA, Rapoport A. Neck dissection in squamous cell carcinoma of the larynx: indication of elective contralateral neck dissection. Braz J Otorhinolaryngol. 2012; Apr. 78(2):7–10.

192. Marks JE, Devineni VR, Harvey J, Sessions DG. The risk of contralateral lymphatic metastases for cancers of the larynx and pharynx. Am J Otolaryngol. 1992; Jan-Feb. 13(1):34–9.

193. Olsen KD, DeSanto LW, Pearson BW. Positive Delphian lymph node: clinical significance in laryngeal cancer. Laryngoscope. 1987; Sep. 97(9):1033–7.

194. Yang CY, Andersen PE, Everts EC, Cohen JI. Nodal disease in purely glottis carcinoma: is elective neck treatment worthwhile. Laryngoscope. 1998; Jul. 108(7):1006–8.

195. Erdag TK, Guneri EA, Avincsal O, Sarioglu S, Ecevit MC, Guneri A, et al. Is elective neck dissection necessary for the surgical management of T2N0 glottic carcinoma? Auris Nasus Larynx. 2013; Feb. 40(1):85–8.

196. Ma H, Lian M, Feng L, Li P, Hou L, Liu H, et al. Management of cervical lymph nodes for cN0 advanced glottic laryngeal carcinoma and its long-term results. Acta Otolaryngol. 2014; Sep. 134(9):952–8.

197. Mendenhall WM, Parsons JT, Brant TA, Stringer SP, Cassisi NJ, Million RR. Is elective neck treatment indicated for T2N0 squamous cell carcinoma of the glottis larynx? Radiother Oncol. 1989; Mar. 14(3):199–202.

198. Yuceturk AV, Celik O, Eskiizmir G. The management of glottic and supraglottic cancers of the larynx in relation to neck metastasis. Kulak Burun Bogaz Ihtis Derg. 2003; Nov. 11(5):129–33.

199. Johnson JT. Carcinoma of the larynx: selective approach to the management of cervical lymphatics. Ear Nose Throat J. 1994; May. 73(5):303–5.

200. Deganello A, Gitti G, Meccariello G, Parrinello G, Mannelli G, Gallo O. Effectiveness and pitfalls of elective neck dissection in N0 laryngeal cancer. Acta Otorhinolaryngol Ital. 2011; Aug. 31(4):216–21.

201. Zhang B, Xu ZG, Tang PZ. Elective lateral neck dissection for laryngeal cancer in the clinically negative neck. J Surg Oncol. 2006; May. 93(6):464–7.

202. Pinilla M, Gonzalez FM, Lopez-Cortijo C, Arellano B, Herrero J, Trinidad A, et al. Management of N0 neck in laryngeal carcinoma. Impact on patient’s survival. J Laryngol Otol. 2003; Jan. 117(1):63–6.

203. Greene RM, Dewitt AI, Otto RA. Management of T3 N0 and T4 N0 glottic carcinomas: results of a national survey. Otolaryngol Head Neck Surg. 2003; Feb. 128(2):191–5.

204. Spector GJ, Sessions DG, Lenox J, Newland D, Simpson J, Haughey BH. Management of stage IV glottic carcinoma: therapeutic outcomes. Laryngoscope. 2004; Aug. 114(8):1438–46.

205. Spector JG, Sessions DG, Lenox J, Simpson J. Management of T3N1 glottic carcinoma: therapeutic outcomes. Laryngoscope. 2006; Jan. 116(1):106–10.

206. Mendenhall WM, Parsons JT, Stringer SP, Cassisi NJ. Management of Tis, T1, and T2 squamous cell carcinoma of the glottic larynx. Am J Otolaryngol. 1994; Jul-Aug. 15(4):250–7.

207. Gallo O, Fini-Storchi I, Napolitano L. Treatment of the contralateral negative neck in supraglottic cancer patients with unilateral node metastases (N1-3). Head Neck. 2000; Jul. 22(4):386–92.

208. Shah JP, Medina JE, Shaha AR, Schantz SP, Marti JR. Cervical lymph node metastasis. Curr Probl Surg. 1993; Mar. 30(3):1–335.

209. Shah JP. Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract. Am J Surg. 1990; Oct. 160(4):405–9.

210. Yuen AP, Ho CM, Wei WI, Lam LK. Analysis of recurrence after surgical treatment of advanced laryngeal carcinoma. J Laryngol Otol. 1995; Nov. 109(11):1063–7.

211. Buckley JG, MacLennan K. Cervical node metastases in laryngeal and hypopharyngeal cancer: a prospective analysis of prevalence and distribution. Head Neck. 2000; Jul. 22(4):380–5.

212. Brazilian Head and Neck Cancer Study Group. End results of a prospective trial on elective lateral neck dissection vs type III modified radical neck dissection in the management of supraglottic and transglottic carcinomas. Head Neck. 1999; Dec. 21(8):694–702.

213. Katilmis H, Ozturkcan S, Ozdemir I, Tuna B, Guvenc IA, Ozkul Y. Is dissection of levels 4 and 5 justified for cN0 laryngeal and hypopharyngeal cancer? Acta Otolaryngol. 2007; Nov. 127(11):1202–6.

214. Ferlito A, Silver CE, Rinaldo A. Selective neck dissection (IIA, III): a rational replacement for complete functional neck dissection in patients with N0 supraglottic and glottic squamous carcinoma. Laryngoscope. 2008; Apr. 118(4):676–9.

215. Coskun HH, Erisen L, Basut O. Selective neck dissection for clinically N0 neck in laryngeal cancer: is dissection of level IIb necessary? Otolaryngol Head Neck Surg. 2004; Nov. 131(5):655–9.

216. Santoro R, Franchi A, Gallo O, Burali G, de’ Campora E. Nodal metastases at level IIb during neck dissection for head and neck cancer: clinical and pathologic evaluation. Head Neck. 2008; Nov. 30(11):1483–7.

217. Ferlito A, Silver CE, Rinaldo A. Neck dissection: present and future. Eur Arch Otorhinolaryngol. 2008; Jun. 265(6):621–6.

218. Sezen OS, Kubilay U, Haytoglu S, Unver S. Frequency of metastases at the area of the supraretrospinal (level IIB) lymph node in laryngeal cancer. Head Neck. 2007; Dec. 29(12):1111–4.

219. Zohdi I, El Sharkawy LS, El Bestar MF, Abdel Tawab HM, Hamela MA, Hareedy AA. Selective neck dissection (IIa, III): a rational replacement for extended supraomohyoid neck dissection in patients with N0 supraglottic and glottic squamous cell carcinoma. Clin Med Insights Ear Nose Throat. 2015; Feb. 8:1–6.

220. Park DY, Koo YC, Hong JM, Kim WS, Koh YW, Choi EC. Oncologic and functional outcomes of supraglottic partial laryngectomy: 18 years experience. Korean J Otorhinolaryngol-Head Neck Surg. 2012; May. 55(5):295–300.

221. Spriano G, Antognoni P, Piantanida R, Varinelli D, Luraghi R, Cerizza L, et al. Conservative management of T1-T2N0 supraglottic cancer: a retrospective study. Am J Otolaryngol. 1997; Sep-Oct. 18(5):299–305.

222. Bron LP, Soldati D, Monod ML, Megevand C, Brossard E, Monnier P, et al. Horizontal partial laryngectomy for supraglottic squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2005; Apr. 262(4):302–6.

223. Sevilla MA, Rodrigo JP, Llorente JL, Cabanillas R, Lopez F, Suarez C. Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol. 2008; Jan. 265(1):11–6.

224. Bocca E, Pignataro O, Oldini C. Supraglottic laryngectomy: 30 years of experience. Ann Otol Rhinol Laryngol. 1983; Jan-Feb. 92(1 Pt 1):14–8.

225. Robbins KT, Davidson W, Peters LJ, Goepfert H. Conservation surgery for T2 and T3 carcinomas of the supraglottic larynx. Arch Otolaryngol Head Neck Surg. 1988; Apr. 114(4):421–6.

226. Chang J, Jang M, Jung EJ, Baek SK, Kwan SY, Woo JS, et al. Clinical outcome of supraglottic laryngectomy in supraglottic cancer: open vs transoral laser supraglottic laryngectomy. Korean J Otorhinolaryngol-Head Neck Surg. 2007; Dec. 50(12):1130–4.

227. Davis RK, Kriskovich MD, Galloway EB 3rd, Buntin CS, Jepsen MC. Endoscopic supraglottic laryngectomy with postoperative irradiation. Ann Otol Rhinol Laryngol. 2004; Feb. 113(2):132–8.

228. Davis RK, Shapshay SM, Strong MS, Hyams VJ. Transoral partial supraglottic resection using the CO2 laser. Laryngoscope. 1983; Apr. 93(4):429–32.

229. Chun JY, Kim YH, Choi EC, Byeon HK, Jung J, Kim SH. The oncologic safety and functional preservation of supraglottic partial laryngectomy. Am J Otolaryngol. 2010; Jul-Aug. 31(4):246–51.

230. Peretti G, Piazza C, Cattaneo A, De Benedetto L, Martin E, Nicolai P. Comparison of functional outcomes after endoscopic versus open-neck supraglottic laryngectomies. Ann Otol Rhinol Laryngol. 2006; Nov. 115(11):827–32.

231. Sasaki CT, Leder SB, Acton LM, Maune S. Comparison of the glottic closure reflex in traditional “open” versus endoscopic laser supraglottic laryngectomy. Ann Otol Rhinol Laryngol. 2006; Feb. 115(2):93–6.

232. Cabanillas R, Rodrigo JP, Llorente JL, Suarez V, Ortega P, Suarez C. Functional outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2004; Aug. 26(8):653–9.

233. Ambrosch P, Kron M, Steiner W. Carbon dioxide laser microsurgery for early supraglottic carcinoma. Ann Otol Rhinol Laryngol. 1998; Aug. 107(8):680–8.

234. Rudert HH, Werner JA. Endoscopic resections of glottic and supraglottic carcinomas with the CO2 laser. Eur Arch Otorhinolaryngol. 1995; 252(3):146–8.

235. Iro H, Waldfahrer F, Altendorf-Hofmann A, Weidenbecher M, Sauer R, Steiner W. Transoral laser surgery of supraglottic cancer: followup of 141 patients. Arch Otolaryngol Head Neck Surg. 1998; Nov. 124(11):1245–50.

236. Cabanillas R, Rodrigo JP, Llorente JL, Suarez C. Oncologic outcomes of transoral laser surgery of supraglottic carcinoma compared with a transcervical approach. Head Neck. 2008; Jun. 30(6):750–5.

237. Park YM, Byeon HK, Chung HP, Choi EC, Kim SH. Comparison of treatment outcomes after transoral robotic surgery and supraglottic partial laryngectomy: our experience with seventeen and seventeen patients respectively. Clin Otolaryngol. 2013; Jun. 38(3):270–4.

238. Ansarin M, Zorzi S, Massaro MA, Tagliabue M, Proh M, Giugliano G, et al. Transoral robotic surgery vs transoral laser microsurgery for resection of supraglottic cancer: a pilot surgery. Int J Med Robot. 2014; Mar. 10(1):107–12.

239. Orus C, Leon X, Vega M, Quer M. Initial treatment of the early stages (I, II) of supraglottic squamous cell carcinoma: partial laryngectomy versus radiotherapy. Eur Arch Otorhinolaryngol. 2000; Nov. 257(9):512–6.

240. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, et al. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope. 2006; Sep. 116(9 Pt 2 Suppl 111):1–13.

241. Myers EN, Alvi A. Management of carcinoma of the supraglottic larynx: evolution, current concepts, and future trends. Laryngoscope. 1996; May. 106(5 Pt 1):559–67.

242. Sessions DG, Lenox J, Spector GJ. Supraglottic laryngeal cancer: analysis of treatment results. Laryngoscope. 2005; Aug. 115(8):1402–10.

243. Lefebvre JL. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol. 2006; Sep. 7(9):747–55.

244. Grant DG, Salassa JR, Hinni ML, Pearson BW, Hayden RE, Perry WC. Transoral laser microsurgery for carcinoma of the supraglottic larynx. Otolaryngol Head Neck Surg. 2007; Jun. 136(6):900–6.

245. Canis M, Martin A, Ihler F, Wolff HA, Kron M, Matthias C, et al. Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients. Eur Arch Otorhinolaryngol. 2013; Aug. 270(8):2315–26.

246. Joo YH, Sun DI, Kim CS, Cho KJ, Cho SH, Kim MS. The role of conservation laryngeal surgery in locally advanced laryngeal cancer. Korean J Otorhinolaryngol-Head Neck Surg. 2007; Oct. 50(10):924–8.

247. Lee NK, Goepfert H, Wendt CD. Supraglottic laryngectomy for intermediate-stage cancer: U.T. M.D. Anderson Cancer Center experience with combined therapy. Laryngoscope. 1990; Aug. 100(8):831–6.

248. Holsinger FC, Weinstein GS, Laccourreye O. Supracricoid partial laryngectomy: an organ-preservation surgery for laryngeal malignancy. Curr Probl Cancer. 2005; Jul-Aug. 29(4):190–200.

249. Bron L, Brossard E, Monnier P, Pasche P. Supracricoid partial laryngectomy with cricohyoidoepiglottopexy and cricohyoidopexy for glottic and supraglottic carcinomas. Laryngoscope. 2000; Apr. 110(4):627–34.

250. Gallo A, Manciocco V, Simonelli M, Pagliuca G, D’Arcangelo E, de Vincentiis M. Supracricoid partial laryngectomy in the treatment of laryngeal cancer: univariate and multivariate analysis of prognostic factors. Arch Otolaryngol Head Neck Surg. 2005; Jul. 131(7):620–5.

251. Gregor RT, Oei SS, Hilgers FJ, Hart AA, Balm AJ, Keus RB. Management of cervical metastases in supraglottic cancer. Ann Otol Rhinol Laryngol. 1996; Nov. 105(11):845–50.

252. Brasilino de Carvalho M. Quantitative analysis of the extent of extracapsular invasion and its prognostic significance: a prospective study of 170 cases of carcinoma of the larynx and hypopharynx. Head Neck. 1998; Jan. 20(1):16–21.

253. Hahn SS, Spaulding CA, Kim JA, Constable WC. The prognostic significance of lymph node involvement in pyriform sinus and supraglottic cancers. Int J Radiat Oncol Biol Phys. 1987; Aug. 13(8):1143–7.

254. Santos CR, Kowalski LP, Magrin J, Fogaroli RC, Santos JC, Saboia MV, et al. Prognostic factors in supraglottic carcinoma patients treated by surgery or radiotherapy. Ann Otol Rhinol Laryngol. 1998; Aug. 107(8):697–702.

255. Zamora RL, Harvey JE, Sessions DG, Spitznagel EL Jr. Clinical staging for primary malignancies of the supraglottic larynx. Laryngoscope. 1993; Jan. 103(1 Pt 1):69–77.

256. Moe K, Wolf GT, Fisher SG, Hong WK. Regional metastases in patients with advanced laryngeal cancer. Department of Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg. 1996; Jun. 122(6):644–8.

257. Allegra E, Franco T, Domanico R, La Boria A, Trapasso S, Garozzo A. Effectiveness of therapeutic selective neck dissection in laryngeal cancer. ORL J Otorhinolaryngol Relat Spec. 2014; Jun. 76(2):89–97.

258. Antonio JK, Menezes MB, Kavabata NK, Bertelli AA, Kikuchi W, Goncalves AJ. Selective neck dissection for treating node-positive necks in cases of squamous cell carcinoma of the upper aerodigestive tract. Sao Paulo Med J. 2008; Mar. 126(2):112–8.

259. Patel RS, Clark JR, Gao K, O’Brien CJ. Effectiveness of selective neck dissection in the treatment of the clinically positive neck. Head Neck. 2008; Sep. 30(9):1231–6.

260. Robbins KT, Ferlito A, Shah JP, Hamoir M, Takes RP, Strojan P, et al. The evolving role of selective neck dissection for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013; Mar. 270(4):1195–202.

261. Hicks WL Jr, Kollmorgen DR, Kuriakose MA, Orner J, Bakamjian VY, Winston J, et al. Patterns of nodal metastasis and surgical management of the neck in supraglottic laryngeal carcinoma. Otolaryngol Head Neck Surg. 1999; Jul. 121(1):57–61.

262. Petrovic Z, Krejovic B, Janosevic S. Occult metastases from supraglottic laryngeal carcinoma. Clin Otolaryngol Allied Sci. 1997; Dec. 22(6):522–4.

263. Esposito ED, Motta S, Cassiano B, Motta G. Occult lymph node metastases in supraglottic cancers of the larynx. Otolaryngol Head Neck Surg. 2001; Mar. 124(3):253–7.

264. Scola B, Fernandez-Vega M, Martinez T, Fernandez-Vega S, Ramirez C. Management of cancer of the supraglottis. Otolaryngol Head Neck Surg. 2001; Feb. 124(2):195–8.

265. Djordjevic V, Bukurov B, Arsovic N, Dimitrijevic M, Jesic S, Nesic V, et al. Prospective case-control study of efficacy of bilateral selective neck dissection in primary surgical treatment of supraglottic laryngeal cancers with clinically negative cervical findings (N0). Clin Otolaryngol. 2015; Oct. 23. [Epub]. http://dx.doi.org/10.1111/coa.12570.

266. Weber PC, Johnson JT, Myers EN. The impact of bilateral neck dissection on pattern of recurrence and survival in supraglottic carcinoma. Arch Otolaryngol Head Neck Surg. 1994; Jul. 120(7):703–6.

267. Redaelli de Zinis LO, Nicolai P, Tomenzoli D, Ghizzardi D, Trimarchi M, Cappiello J, et al. The distribution of lymph node metastases in supraglottic squamous cell carcinoma: therapeutic implications. Head Neck. 2002; Oct. 24(10):913–20.

268. Chaaban MR. Management of the N0 neck treatment & management [Internet]. Medscape;2015. [cited 2016 Nov 7]. Available from: http://emedicine.medscape.com/article/850469-treatment#d10.

269. Tomifuji M, Imanishi Y, Araki K, Yamashita T, Yamamoto S, Kameyama K, et al. Tumor depth as a predictor of lymph node metastasis of supraglottic and hypopharyngeal cancers. Ann Surg Oncol. 2011; Feb. 18(2):490–6.

270. Tu GY. Upper neck (level II) dissection for N0 neck supraglottic carcinoma. Laryngoscope. 1999; Mar. 109(3):467–70.

271. Andersen PE, Cambronero E, Shaha AR, Shah JP. The extent of neck disease after regional failure during observation of the N0 neck. Am J Surg. 1996; Dec. 172(6):689–91.

272. Gregor RT, Oei SS, Baris G, Keus RB, Balm AJ, Hilgers FJ. Supraglottic laryngectomy with postoperative radiation versus primary radiation in the management of supraglottic laryngeal cancer. Am J Otolaryngol. 1996; Sep-Oct. 17(5):316–21.

273. Rodrigo JP, Cabanillas R, Franco V, Suarez C. Efficacy of routine bilateral neck dissection in the management of the N0 neck in T1-T2 unilateral supraglottic cancer. Head Neck. 2006; Jun. 28(6):534–9.

274. van den Brekel MW, van der Waal I, Meijer CJ, Freeman JL, Castelijns JA, Snow GB. The incidence of micrometastases in neck dissection specimens obtained from elective neck dissections. Laryngoscope. 1996; Aug. 106(8):987–91.

275. Lutz CK, Johnson JT, Wagner RL, Myers EN. Supraglottic carcinoma: patterns of recurrence. Ann Otol Rhinol Laryngol. 1990; Jan. 99(1):12–7.

276. Chiu RJ, Myers EN, Johnson JT. Efficacy of routine bilateral neck dissection in the management of supraglottic cancer. Otolaryngol Head Neck Surg. 2004; Oct. 131(4):485–8.

277. Guney E, Yigitbasi OG. Management of N0 neck in T1-T2 unilateral supraglottic cancer. Ann Otol Rhinol Laryngol. 1999; Oct. 108(10):998–1003.

278. Ozturkcan S, Katilmis H, Ozdemir I, Tuna B, Guvenc IA, Dundar R. Occult contralateral nodal metastases in supraglottic laryngeal cancer crossing the midline. Eur Arch Otorhinolaryngol. 2009; Jan. 266(1):117–20.

279. Elsheikh MN, Mahfouz ME, Salim EI, Elsheikh EA. Molecular assessment of neck dissections supports preserving level IIB lymph nodes in selective neck dissection for laryngeal squamous cell carcinoma with a clinically negative neck. ORL J Otorhinolaryngol Relat Spec. 2006; 68(3):177–84.

280. Jia S, Wang Y, He H, Xiang C. Incidence of level IIB lymph node metastasis in supraglottic laryngeal squamous cell carcinoma with clinically negative neck: a prospective study. Head Neck. 2013; Jul. 35(7):987–91.

281. Lim YC, Lee JS, Koo BS, Choi EC. Level IIb lymph node metastasis in laryngeal squamous cell carcinoma. Laryngoscope. 2006; Feb. 116(2):268–72.

282. Makitie AA, Irish J, Gullane PJ. Pharyngocutaneous fistula. Curr Opin Otolaryngol Head Neck Surg. 2003; Apr. 11(2):78–84.

283. Markou KD, Vlachtsis KC, Nikolaou AC, Petridis DG, Kouloulas AI, Daniilidis IC. Incidence and predisposing factors of pharyngocutaneous fistula formation after total laryngectomy. Is there a relationship with tumor recurrence? Eur Arch Otorhinolaryngol. 2004; Feb. 261(2):61–7.

284. Papazoglou G, Doundoulakis G, Terzakis G, Dokianakis G. Pharyngocutaneous fistula after total laryngectomy: incidence, cause, and treatment. Ann Otol Rhinol Laryngol. 1994; Oct. 103(10):801–5.

285. Dedivitis RA, Aires FT, Cernea CR, Brandao LG. Pharyngocutaneous fistula after total laryngectomy: systematic review of risk factors. Head Neck. 2015; Nov. 37(11):1691–7.

286. Ikiz AO, Uca M, Guneri EA, Erdag TK, Sutay S. Pharyngocutaneous fistula and total laryngectomy: possible predisposing factors, with emphasis on pharyngeal myotomy. J Laryngol Otol. 2000; Oct. 114(10):768–71.

287. Cavalot AL, Gervasio CF, Nazionale G, Albera R, Bussi M, Staffieri A, et al. Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records. Otolaryngol Head Neck Surg. 2000; Nov. 123(5):587–92.

288. Galli J, De Corso E, Volante M, Almadori G, Paludetti G. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Otolaryngol Head Neck Surg. 2005; Nov. 133(5):689–94.

289. Redaelli de Zinis LO, Ferrari L, Tomenzoli D, Premoli G, Parrinello G, Nicolai P. Postlaryngectomy pharyngocutaneous fistula: incidence, predisposing factors, and therapy. Head Neck. 1999; Mar. 21(2):131–8.

290. Liang JW, Li ZD, Li SC, Fang FQ, Zhao YJ, Li YG. Pharyngocutaneous fistula after total laryngectomy: a systematic review and meta-analysis of risk factors. Auris Nasus Larynx. 2015; Oct. 42(5):353–9.

291. Kuo M, Ho CM, Wei WI, Lam KH. Tracheostomal stenosis after total laryngectomy: an analysis of predisposing clinical factors. Laryngoscope. 1994; Jan. 104(1 Pt 1):59–63.

292. Wax MK, Touma BJ, Ramadan HH. Tracheostomal stenosis after laryngectomy: incidence and predisposing factors. Otolaryngol Head Neck Surg. 1995; Sep. 113(3):242–7.

293. De Virgilio A, Greco A, Gallo A, Martellucci S, Conte M, de Vincentiis M. Tracheostomal stenosis clinical risk factors in patients who have undergone total laryngectomy and adjuvant radiotherapy. Eur Arch Otorhinolaryngol. 2013; Nov. 270(12):3187–9.

294. Gal RL, Gal TJ, Klotch DW, Cantor AB. Risk factors associated with hypothyroidism after laryngectomy. Otolaryngol Head Neck Surg. 2000; Sep. 123(3):211–7.

295. Lo Galbo AM, de Bree R, Kuik DJ, Lips PT, Mary B, Von Blomberg E, et al. The prevalence of hypothyroidism after treatment for laryngeal and hypopharyngeal carcinomas: are autoantibodies of influence? Acta Otolaryngol. 2007; Mar. 127(3):312–7.

296. Aimoni C, Scanelli G, D’agostino L, Pastore A. Thyroid function studies in patients with cancer of the larynx: preliminary evaluation. Otolaryngol Head Neck Surg. 2003; Dec. 129(6):733–8.

297. Mercado G, Adelstein DJ, Saxton JP, Secic M, Larto MA, Lavertu P. Hypothyroidism: a frequent event after radiotherapy and after radiotherapy with chemotherapy for patients with head and neck carcinoma. Cancer. 2001; Dec. 92(11):2892–7.

298. Kiyota N, Tahara M, Fujii M. Adjuvant treatment for post-operative head and neck squamous cell carcinoma. Jpn J Clin Oncol. 2015; Jan. 45(1):2–6.

299. Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001; Nov. 51(3):571–8.

300. Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med. 2004; May. 350(19):1937–44.

301. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med. 2004; May. 350(19):1945–52.

302. Bernier J, Cooper JS, Pajak TF, van Glabbeke M, Bourhis J, Forastiere A, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005; Oct. 27(10):843–50.

303. Cooper JS, Zhang Q, Pajak TF, Forastiere AA, Jacobs J, Saxman SB, et al. Long-term follow-up of the RTOG 9501/intergroup phase III trial: postoperative concurrent radiation therapy and chemotherapy in high-risk squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012; Dec. 84(5):1198–205.

304. Rademaker AW, Logemann JA, Pauloski BR, Bowman JB, Lazarus CL, Sisson GA, et al. Recovery of postoperative swallowing in patients undergoing partial laryngectomy. Head Neck. 1993; JulAug. 15(4):325–34.

305. Jovic R, Majdevac Z. Swallowing and breathing after partial resection of the larynx. Srp Arh Celok Lek. 1994; Nov-Dec. 122(11-12):319–22.

306. Sessions DG, Zill R, Schwartz SL. Deglutition after conservation surgery for cancer of the larynx and hypopharynx. Otolaryngol Head Neck Surg (1979). 1979; Nov-Dec. 87(6):779–96.

307. Tufano RP, Stafford EM. Organ preservation surgery for laryngeal cancer. Otolaryngol Clin North Am. 2008; Aug. 41(4):741–55.

308. Logemann JA, Gibbons P, Rademaker AW, Pauloski BR, Kahrilas PJ, Bacon M, et al. Mechanisms of recovery of swallow after supraglottic laryngectomy. J Speech Hear Res. 1994; Oct. 37(5):965–74.

309. Kreuzer SH, Schima W, Schober E, Pokieser P, Kofler G, Lechner G, et al. Complications after laryngeal surgery: videofluoroscopic evaluation of 120 patients. Clin Radiol. 2000; Oct. 55(10):775–81.

310. Lips M, Speyer R, Zumach A, Kross KW, Kremer B. Supracricoid laryngectomy and dysphagia: a systematic literature review. Laryngoscope. 2015; Sep. 125(9):2143–56.

311. de Vincentiis M, Minni A, Gallo A, Di Nardo A. Supracricoid partial laryngectomies: oncologic and functional results. Head Neck. 1998; Sep. 20(6):504–9.

312. Karasalihoglu AR, Yagiz R, Tas A, Uzun C, Adali MK, Koten M. Supracricoid partial laryngectomy with cricohyoidopexy and cricohyoidoepiglottopexy: functional and oncological results. J Laryngol Otol. 2004; Sep. 118(9):671–5.

313. Pinar E, Imre A, Calli C, Oncel S, Katilmis H. Supracricoid partial laryngectomy: analyses of oncologic and functional outcomes. Otolaryngol Head Neck Surg. 2012; Dec. 147(6):1093–8.

314. McConnel FM, Mendelsohn MS, Logemann JA. Examination of swallowing after total laryngectomy using manofluorography. Head Neck Surg. 1986; Sep-Oct. 9(1):3–12.

315. Lazarus CL, Logemann JA, Pauloski BR, Colangelo LA, Kahrilas PJ, Mittal BB, et al. Swallowing disorders in head and neck cancer patients treated with radiotherapy and adjuvant chemotherapy. Laryngoscope. 1996; Sep. 106(9 Pt 1):1157–66.

316. Ott DJ, Hodge RG, Pikna LA, Chen MY, Gelfand DW. Modified barium swallow: clinical and radiographic correlation and relation to feeding recommendations. Dysphagia. 1996; Summer. 11(3):187–90.

317. Cook IJ, Kahrilas PJ. AGA technical review on management of oropharyngeal dysphagia. Gastroenterology. 1999; Feb. 116(2):455–78.

318. Mathers-Schmidt BA, Kurlinski M. Dysphagia evaluation practices: inconsistencies in clinical assessment and instrumental examination decision-making. Dysphagia. 2003; Spring. 18(2):114–25.

319. Doggett DL, Turkelson CM, Coates V. Recent developments in diagnosis and intervention for aspiration and dysphagia in stroke and other neuromuscular disorders. Curr Atheroscler Rep. 2002; Jul. 4(4):311–8.

320. Martin-Harris B, Logemann JA, McMahon S, Schleicher M, Sandidge J. Clinical utility of the modified barium swallow. Dysphagia. 2000; Summer. 15(3):136–41.

321. Logemann JA, Rademaker AW, Pauloski BR, Kahrilas PJ. Effects of postural change on aspiration in head and neck surgical patients. Otolaryngol Head Neck Surg. 1994; Feb. 110(2):222–7.

322. Rasley A, Logemann JA, Kahrilas PJ, Rademaker AW, Pauloski BR, Dodds WJ. Prevention of barium aspiration during videofluoroscopic swallowing studies: value of change in posture. AJR Am J Roentgenol. 1993; May. 160(5):1005–9.

323. Lazarus C, Logemann JA, Gibbons P. Effects of maneuvers on swallowing function in a dysphagic oral cancer patient. Head Neck. 1993; Sep-Oct. 15(5):419–24.

324. Zuydam AC, Rogers SN, Brown JS, Vaughan ED, Magennis P. Swallowing rehabilitation after oro-pharyngeal resection for squamous cell carcinoma. Br J Oral Maxillofac Surg. 2000; Oct. 38(5):513–8.

325. Kawai S, Tsukuda M, Mochimatu I, Kono H, Enomoto H, Ikema Y, et al. The benefit of head rotation on pharyngoesophageal dysphagia from three cases of paraganglioma in the parapharyngeal space. Nihon Jibiinkoka Gakkai Kaiho. 1999; Mar. 102(3):311–6.

326. Martin BJ, Logemann JA, Shaker R, Dodds WJ. Normal laryngeal valving patterns during three breath-hold maneuvers: a pilot investigation. Dysphagia. 1993; 8(1):11–20.

327. Kahrilas PJ, Logemann JA, Krugler C, Flanagan E. Volitional augmentation of upper esophageal sphincter opening during swallowing. Am J Physiol. 1991; Mar. 260(3 Pt 1):G450–6.

328. Logemann JA, Pauloski BR, Rademaker AW, Colangelo LA. Supersupraglottic swallow in irradiated head and neck cancer patients. Head Neck. 1997; Sep. 19(6):535–40.

329. Tang CG, Sinclair CF. Voice restoration after total laryngectomy. Otolaryngol Clin North Am. 2015; Aug. 48(4):687–702.

330. Brown DH, Hilgers FJ, Irish JC, Balm AJ. Postlaryngectomy voice rehabilitation: state of the art at the millennium. World J Surg. 2003; Jul. 27(7):824–31.

331. Gates GA, Hearne EM 3rd. Predicting esophageal speech. Ann Otol Rhinol Laryngol. 1982; Jul-Aug. 91(4 Pt 1):454–7.

332. Clark JG, Stemple JC. Assessment of three modes of alaryngeal speech with a synthetic sentence identification (SSI) task in varying message-to-competition ratios. J Speech Hear Res. 1982; Sep. 25(3):333–8.

333. Max L, Steurs W, de Bruyn W. Vocal capacities in esophageal and tracheoesophageal speakers. Laryngoscope. 1996; Jan. 106(1 Pt 1):93–6.

334. Culton GL, Gerwin JM. Current trends in laryngectomy rehabilitation: a survey of speech-language pathologists. Otolaryngol Head Neck Surg. 1998; Apr. 118(4):458–63.

335. Dworkin JP, Banton A. Oesophageal and mechanical instrument speech rehabilitation for the laryngectomee. Clin Otolaryngol Allied Sci. 1982; Aug. 7(4):269–77.

336. Norton RL, Bernstein RS. Improved LAboratory Prototype ELectrolarynx (LAPEL): using inverse filtering of the frequency response function of the human throat. Ann Biomed Eng. 1993; MarApr. 21(2):163–74.

337. Cox SR, Doyle PC. The influence of electrolarynx use on postlaryngectomy voice-related quality of life. Otolaryngol Head Neck Surg. 2014; Jun. 150(6):1005–9.

338. Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK. Functional outcomes following treatment for advanced laryngeal cancer. Part I: voice preservation in advanced laryngeal cancer. Part II: laryngectomy rehabilitation: the state of the art in the VA system. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol Suppl. 1998; May. 172:1–27.

339. Miyoshi M, Fukuhara T, Kataoka H, Hagino H. Relationship between quality of life instruments and phonatory function in tracheoesophageal speech with voice prosthesis. Int J Clin Oncol. 2016; Apr. 21(2):402–8.

340. Hilgers FJ, Schouwenburg PF. A new low-resistance, self-retaining prosthesis (Provox) for voice rehabilitation after total laryngectomy. Laryngoscope. 1990; Nov. 100(11):1202–7.

341. Hilgers FJ, Cornelissen MW, Balm AJ. Aerodynamic characteristics of the Provox low-resistance indwelling voice prosthesis. Eur Arch Otorhinolaryngol. 1993; 250(7):375–8.

342. Robbins J. Acoustic differentiation of laryngeal, esophageal, and tracheoesophageal speech. J Speech Hear Res. 1984; Dec. 27(4):577–85.

343. Robbins J, Fisher HB, Blom EC, Singer MI. A comparative acoustic study of normal, esophageal, and tracheoesophageal speech production. J Speech Hear Disord. 1984; May. 49(2):202–10.

344. Dabholkar JP, Kapre NM, Gupta HK. Results of voice rehabilitation with provox prosthesis and factors affecting the voice quality. J Voice. 2015; Nov. 29(6):777. e1-8.

345. Ackerstaff AH, Hilgers FJ, Aaronson NK, Balm AJ. Communication, functional disorders and lifestyle changes after total laryngectomy. Clin Otolaryngol Allied Sci. 1994; Aug. 19(4):295–300.

346. Singer MI, Blom ED. An endoscopic technique for restoration of voice after laryngectomy. Ann Otol Rhinol Laryngol. 1980; Nov-Dec. 89(6 Pt 1):529–33.

347. Guttman D, Mizrachi A, Hadar T, Bachar G, Hamzani Y, Marx S, et al. Post-laryngectomy voice rehabilitation: comparison of primary and secondary tracheoesophageal puncture. Isr Med Assoc J. 2013; Sep. 15(9):497–9.

348. Bradley PJ, Ferlito A, Silver CE, Takes RP, Woolgar JA, Strojan P, et al. Neck treatment and shoulder morbidity: still a challenge. Head Neck. 2011; Jul. 33(7):1060–7.

349. Salerno G, Cavaliere M, Foglia A, Pellicoro DP, Mottola G, Nardone M, et al. The 11th nerve syndrome in functional neck dissection. Laryngoscope. 2002; Jul. 112(7 Pt 1):1299–307.

350. Nason RW, Abdulrauf BM, Stranc MF. The anatomy of the accessory nerve and cervical lymph node biopsy. Am J Surg. 2000; Sep. 180(3):241–3.

351. Rigual NR, Wiseman SM. Neck dissection: current concepts and future directions. Surg Oncol Clin N Am. 2004; Jan. 13(1):151–66.

352. Tatla T, Kanagalingam J, Majithia A, Clarke PM. Upper neck spinal accessory nerve identification during neck dissection. J Laryngol Otol. 2005; Nov. 119(11):906–8.

353. Leipzig B, Suen JY, English JL, Barnes J, Hooper M. Functional evaluation of the spinal accessory nerve after neck dissection. Am J Surg. 1983; Oct. 146(4):526–30.

354. Dijkstra PU, van Wilgen PC, Buijs RP, Brendeke W, de Goede CJ, Kerst A, et al. Incidence of shoulder pain after neck dissection: a clinical explorative study for risk factors. Head Neck. 2001; Nov. 23(11):947–53.

355. Eickmeyer SM, Walczak CK, Myers KB, Lindstrom DR, Layde P, Campbell BH. Quality of life, shoulder range of motion, and spinal accessory nerve status in 5-year survivors of head and neck cancer. PM R. 2014; Dec. 6(12):1073–80.

356. van Wilgen CP, Dijkstra PU, Nauta JM, Vermey A, Roodenburg JL. Shoulder pain and disability in daily life, following supraomohyoid neck dissection: a pilot study. J Craniomaxillofac Surg. 2003; Jun. 31(3):183–6.

357. Caversaccio M, Negri S, Nolte LP, Zbaren P. Neck dissection shoulder syndrome: quantification and three-dimensional evaluation with an optoelectronic tracking system. Ann Otol Rhinol Laryngol. 2003; Nov. 112(11):939–46.

358. Zhang B, Tang PZ, Xu ZG, Qi YF, Wang XL. Functional evaluation of the selective neck dissection in patients with carcinoma of head and neck. Zhonghua Er Bi Yan Hou Ke Za Zhi. 2004; Jan. 39(1):28–31.

359. Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg. 2004; Feb. 130(2):149–54.

360. Herring D, King AI, Connelly M. New rehabilitation concepts in management of radical neck dissection syndrome: a clinical report. Phys Ther. 1987; Jul. 67(7):1095–9.

361. Celik B, Coskun H, Kumas FF, Irdesel J, Zarifoglu M, Erisen L, et al. Accessory nerve function after level 2b-preserving selective neck dissection. Head Neck. 2009; Nov. 31(11):1496–501.

362. Birinci Y, Genc A, Ecevit MC, Erdag TK, Guneri EA, Oztura I, et al. Spinal accessory nerve monitoring and clinical outcome results of nerve-sparing neck dissections. Otolaryngol Head Neck Surg. 2014; Aug. 151(2):253–9.

363. Lauchlan DT, McCaul JA, McCarron T. Neck dissection and the clinical appearance of post-operative shoulder disability: the postoperative role of physiotherapy. Eur J Cancer Care (Engl). 2008; Nov. 17(6):542–8.

364. Okajima S, Tamai K, Fujiwara H, Kobashi H, Hirata M, Kubo T. Surgical treatment for spinal accessory nerve injury. Microsurgery. 2006; 26(4):273–7.

365. Park SH, Esquenazi Y, Kline DG, Kim DH. Surgical outcomes of 156 spinal accessory nerve injuries caused by lymph node biopsy procedures. J Neurosurg Spine. 2015; Oct. 23(4):518–25.

366. Stuiver MM, van Wilgen CP, de Boer EM, de Goede CJ, Koolstra M, van Opzeeland A, et al. Impact of shoulder complaints after neck dissection on shoulder disability and quality of life. Otolaryngol Head Neck Surg. 2008; Jul. 139(1):32–9.

367. McNeely ML, Parliament MB, Seikaly H, Jha N, Magee DJ, Haykowsky MJ, et al. Effect of exercise on upper extremity pain and dysfunction in head and neck cancer survivors: a randomized controlled trial. Cancer. 2008; Jul. 113(1):214–22.

368. Nibu K, Ebihara Y, Ebihara M, Kawabata K, Onitsuka T, Fujii T, et al. Quality of life after neck dissection: a multicenter longitudinal study by the Japanese Clinical Study Group on standardization of treatment for lymph node metastasis of head and neck cancer. Int J Clin Oncol. 2010; Feb. 15(1):33–8.

369. Ehlers SL, Gastineau DA, Patten CA, Decker PA, Rausch SM, Cerhan JR, et al. The impact of smoking on outcomes among patients undergoing hematopoietic SCT for the treatment of acute leukemia. Bone Marrow Transplant. 2011; Feb. 46(2):285–90.

370. Sharma A, Deeb AP, Iannuzzi JC, Rickles AS, Monson JR, Fleming FJ. Tobacco smoking and postoperative outcomes after colorectal surgery. Ann Surg. 2013; Aug. 258(2):296–300.

371. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking: 50 years of progress: a report of the surgeon general. Atlanta: Centers for Disease Control and Prevention (US);2014.

372. Marin VP, Pytynia KB, Langstein HN, Dahlstrom KR, Wei Q, Sturgis EM. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008; Feb. 121(2):451–7.

373. Hoff CM, Grau C, Overgaard J. Effect of smoking on oxygen delivery and outcome in patients treated with radiotherapy for head and neck squamous cell carcinoma: a prospective study. Radiother Oncol. 2012; Apr. 103(1):38–44.

374. Chen AM, Chen LM, Vaughan A, Sreeraman R, Farwell DG, Luu Q, et al. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome. Int J Radiat Oncol Biol Phys. 2011; Feb. 79(2):414–9.

375. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993; Jan. 328(3):159–63.

376. O’Malley M, King AN, Conte M, Ellingrod VL, Ramnath N. Effects of cigarette smoking on metabolism and effectiveness of systemic therapy for lung cancer. J Thorac Oncol. 2014; Jul. 9(7):917–26.

377. Hamilton M, Wolf JL, Rusk J, Beard SE, Clark GM, Witt K, et al. Effects of smoking on the pharmacokinetics of erlotinib. Clin Cancer Res. 2006; Apr. 12(7 Pt 1):2166–71.

378. van der Bol JM, Mathijssen RH, Loos WJ, Friberg LE, van Schaik RH, de Jonge MJ, et al. Cigarette smoking and irinotecan treatment: pharmacokinetic interaction and effects on neutropenia. J Clin Oncol. 2007; Jul. 25(19):2719–26.

379. Samet JM. The 1990 report of the surgeon general: the health benefits of smoking cessation. Am Rev Respir Dis. 1990; Nov. 142(5):993–4.

380. Khuri FR, Kim ES, Lee JJ, Winn RJ, Benner SE, Lippman SM, et al. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial. Cancer Epidemiol Biomarkers Prev. 2001; Aug. 10(8):823–9.

381. Richardson GE, Tucker MA, Venzon DJ, Linnoila RI, Phelps R, Phares JC, et al. Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Ann Intern Med. 1993; Sep. 119(5):383–90.

382. Garces YI, Schroeder DR, Nirelli LM, Croghan GA, Croghan IT, Foote RL, et al. Second primary tumors following tobacco dependence treatments among head and neck cancer patients. Am J Clin Oncol. 2007; Oct. 30(5):531–9.

383. Kotz D, Brown J, West R. ‘Real-world’ effectiveness of smoking cessation treatments: a population study. Addiction. 2014; Mar. 109(3):491–9.

384. Stead LF, Koilpillai P, Fanshawe TR, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016; Mar. 3:CD008286.

385. Stead LF, Lancaster T. Behavioural interventions as adjuncts to pharmacotherapy for smoking cessation. Cochrane Database Syst Rev. 2012; Dec. 12:CD009670.

386. Hughes JR. Dependence potential and abuse liability of nicotine replacement therapies. Biomed Pharmacother. 1989; 43(1):11–7.

387. 2008 PHS Guideline Update Panel. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary. Respir Care. 2008; Sep. 53(9):1217–22.

388. Chen AM, Daly ME, Vazquez E, Courquin J, Luu Q, Donald PJ, et al. Depression among long-term survivors of head and neck cancer treated with radiation therapy. JAMA Otolaryngol Head Neck Surg. 2013; Sep. 139(9):885–9.

389. Ahlberg K, Ekman T, Gaston-Johansson F, Mock V. Assessment and management of cancer-related fatigue in adults. Lancet. 2003; Aug. 362(9384):640–50.

390. van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007; Sep. 18(9):1437–49.

391. Stark D, Kiely M, Smith A, Velikova G, House A, Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol. 2002; Jul. 20(14):3137–48.

392. Leung YW, Li M, Devins G, Zimmermann C, Rydall A, Lo C, et al. Routine screening for suicidal intention in patients with cancer. Psychooncology. 2013; Nov. 22(11):2537–45.

393. Miller M, Mogun H, Azrael D, Hempstead K, Solomon DH. Cancer and the risk of suicide in older Americans. J Clin Oncol. 2008; Oct. 26(29):4720–4.

394. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide in persons with cancer. J Clin Oncol. 2008; Oct. 26(29):4731–8.

395. Walker J, Waters RA, Murray G, Swanson H, Hibberd CJ, Rush RW, et al. Better off dead: suicidal thoughts in cancer patients. J Clin Oncol. 2008; Oct. 26(29):4725–30.

396. Kendal WS. Suicide and cancer: a gender-comparative study. Ann Oncol. 2007; Feb. 18(2):381–7.

397. Pereira da Silva A, Feliciano T, Vaz Freitas S, Esteves S, Almeida E Sousa C. Quality of life in patients submitted to total laryngectomy. J Voice. 2015; May. 29(3):382–8.

398. Braz DS, Ribas MM, Dedivitis RA, Nishimoto IN, Barros AP. Quality of life and depression in patients undergoing total and partial laryngectomy. Clinics (Sao Paulo). 2005; Apr. 60(2):135–42.

399. Yilmaz M, Yener M, Yollu U, Akil F, Haciyev Y, Yargic I, et al. Depression, self-esteem and sexual function in laryngeal cancer patients. Clin Otolaryngol. 2015; Aug. 40(4):349–54.

400. Jacobsen PB, Jim HS. Psychosocial interventions for anxiety and depression in adult cancer patients: achievements and challenges. CA Cancer J Clin. 2008; Jul-Aug. 58(4):214–30.

401. Carvalho AF, Hyphantis T, Sales PM, Soeiro-de-Souza MG, Macedo DS, Cha DS, et al. Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials. Cancer Treat Rev. 2014; Apr. 40(3):349–55.

402. Dy SM, Lorenz KA, Naeim A, Sanati H, Walling A, Asch SM. Evidence-based recommendations for cancer fatigue, anorexia, depression, and dyspnea. J Clin Oncol. 2008; Aug. 26(23):3886–95.

403. Hart SL, Hoyt MA, Diefenbach M, Anderson DR, Kilbourn KM, Craft LL, et al. Meta-analysis of efficacy of interventions for elevated depressive symptoms in adults diagnosed with cancer. J Natl Cancer Inst. 2012; Jul. 104(13):990–1004.

404. Laoutidis ZG, Mathiak K. Antidepressants in the treatment of depression/depressive symptoms in cancer patients: a systematic review and meta-analysis. BMC Psychiatry. 2013; May. 13:140.

405. Piet J, Wurtzen H, Zachariae R. The effect of mindfulness-based therapy on symptoms of anxiety and depression in adult cancer patients and survivors: a systematic review and meta-analysis. J Consult Clin Psychol. 2012; Dec. 80(6):1007–20.

406. Walker J, Sawhney A, Hansen CH, Ahmed S, Martin P, Symeonides S, et al. Treatment of depression in adults with cancer: a systematic review of randomized controlled trials. Psychol Med. 2014; Apr. 44(5):897–907.

407. Agra IM, Ferlito A, Takes RP, Silver CE, Olsen KD, Stoeckli SJ, et al. Diagnosis and treatment of recurrent laryngeal cancer following initial nonsurgical therapy. Head Neck. 2012; May. 34(5):727–35.

408. Roland NJ, Paleri V. Head and neck cancer: multidisciplinary management guidelines. 4th ed. London: ENT-UK;2011.

409. Joshi A, Calman F, O’Connell M, Jeannon JP, Pracy P, Simo R. Current trends in the follow-up of head and neck cancer patients in the UK. Clin Oncol (R Coll Radiol). 2010; Mar. 22(2):114–8.

410. Digonnet A, Hamoir M, Andry G, Haigentz M Jr, Takes RP, Silver CE, et al. Post-therapeutic surveillance strategies in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013; May. 270(5):1569–80.

411. Digonnet A, Hamoir M, Andry G, Vander Poorten V, Haigentz M Jr, Langendijk JA, et al. Follow-up strategies in head and neck cancer other than upper aerodigestive tract squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2013; Jul. 270(7):1981–9.

412. Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol. 2001; May. 258(4):177–83.

413. Collins R, Flynn A, Melville A, Richardson R, Eastwood A. Effective health care: management of head and neck cancers. Qual Saf Health Care. 2005; Apr. 14(2):144–8.

414. Morton RP, Hay KD, Macann A. On completion of curative treatment of head and neck cancer: why follow up? Curr Opin Otolaryngol Head Neck Surg. 2004; Apr. 12(2):142–6.

415. Boysen M, Lovdal O, Tausjo J, Winther F. The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer. 1992; Feb-Mar. 28(2-3):426–30.

416. Virgo KS, Paniello RC, Johnson FE. Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg. 1998; May. 124(5):564–72.

417. van Agthoven M, van Ineveld BM, de Boer MF, Leemans CR, Knegt PP, Snow GB, et al. The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up. Eur J Cancer. 2001; Nov. 37(17):2204–11.

418. British Association of Head and Neck Oncologists. Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol. 2001; Jun. 27 Suppl A:S1–17.

419. Marchant FE, Lowry LD, Moffitt JJ, Sabbagh R. Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J Otolaryngol. 1993; Mar-Apr. 14(2):88–93.

420. Comert E, Tuncel U, Torun MT, Kilic C, Cengiz AB, Sencan Z, et al. Pectoralis major myofascial flap in salvage laryngectomy. J Laryngol Otol. 2014; Aug. 128(8):714–9.

421. Kothari P, Trinidade A, Hewitt RJ, Singh A, O’Flynn P. The followup of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol. 2011; Aug. 268(8):1191–200.

422. Trinidade A, Kothari P, Andreou Z, Hewitt RJ, O’Flynn P. Follow-up in head and neck cancer: patients’ perspective. Int J Health Care Qual Assur. 2012; 25(2):145–9.

423. Gugatschka M, Kiesler K, Beham A, Rechenmacher J, Friedrich G. Hyperplastic epithelial lesions of the vocal folds: combined use of exfoliative cytology and laryngostroboscopy in differential diagnosis. Eur Arch Otorhinolaryngol. 2008; Jul. 265(7):797–801.

424. de Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg. 1994; Sep. 120(9):934–9.

425. Engelen AM, Stalpers LJ, Manni JJ, Ruijs JH, van Daal WA. Yearly chest radiography in the early detection of lung cancer following laryngeal cancer. Eur Arch Otorhinolaryngol. 1992; 249(7):364–9.

426. Warner GC, Cox GJ. Evaluation of chest radiography versus chest computed tomography in screening for pulmonary malignancy in advanced head and neck cancer. J Otolaryngol. 2003; Apr. 32(2):107–9.

427. Steinkamp HJ, Knobber D, Schedel H, Maurer J, Felix R. Palpation and sonography in after-care of head-neck tumor patients: comparison of ultrasound tumor entity parameters. Laryngorhinootologie. 1993; Sep. 72(9):431–8.

428. Westhofen M. Ultrasound B-scans in the follow-up of head and neck tumors. Head Neck Surg. 1987; May-Jun. 9(5):272–8.

429. Ahuja A, Leung SF, Ying M, Metreweli C. Echography of metastatic nodes treated by radiotherapy. J Laryngol Otol. 1999; Nov. 113(11):993–8.

430. Steinkamp HJ, Maurer J, Cornehl M, Knobber D, Hettwer H, Felix R. Recurrent cervical lymphadenopathy: differential diagnosis with color-duplex sonography. Eur Arch Otorhinolaryngol. 1994; 251(7):404–9.

431. Schwartz DL, Barker J Jr, Chansky K, Yueh B, Raminfar L, Drago P, et al. Postradiotherapy surveillance practice for head and neck squamous cell carcinoma: too much for too little? Head Neck. 2003; Dec. 25(12):990–9.

432. Hermans R, Pameijer FA, Mancuso AA, Parsons JT, Mendenhall WM. Laryngeal or hypopharyngeal squamous cell carcinoma: can follow-up CT after definitive radiation therapy be used to detect local failure earlier than clinical examination alone? Radiology. 2000; Mar. 214(3):683–7.

433. Ul-Hassan F, Simo R, Guerrero-Urbano T, Oakley R, Jeannon JP, Cook GJ. Can (18)F-FDG PET/CT reliably assess response to primary treatment of head and neck cancer? Clin Nucl Med. 2013; Apr. 38(4):263–5.

434. Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy. Clin Otolaryngol. 2008; Jun. 33(3):210–22.

435. Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, et al. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck. 2008; Jul. 30(7):889–97.

436. Gordin A, Daitzchman M, Doweck I, Yefremov N, Golz A, Keidar Z, et al. Fluorodeoxyglucose-positron emission tomography/computed tomography imaging in patients with carcinoma of the larynx: diagnostic accuracy and impact on clinical management. Laryngoscope. 2006; Feb. 116(2):273–8.

437. Preuss SF, Cramer K, Drebber U, Klussmann JP, Eckel HE, Guntinas-Lichius O. Second-look microlaryngoscopy to detect residual carcinoma in patients after laser surgery for T1 and T2 laryngeal cancer. Acta Otolaryngol. 2009; Aug. 129(8):881–5.

438. Keilmann A, Napiontek U, Engel C, Nakarat T, Schneider A, Mann W. Long-term functional outcome after unilateral cordectomy. ORL J Otorhinolaryngol Relat Spec. 2011; 73(1):38–46.

439. Smit M, Balm AJ, Hilgers FJ, Tan IB. Pain as sign of recurrent disease in head and neck squamous cell carcinoma. Head Neck. 2001; May. 23(5):372–5.

440. O’Meara WP, Thiringer JK, Johnstone PA. Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol. 2003; Mar. 66(3):323–6.

441. Lapela M, Eigtved A, Jyrkkio S, Grenman R, Kurki T, Lindholm P, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer. 2000; May. 36(7):858–67.

442. Manikantan K, Khode S, Dwivedi RC, Palav R, Nutting CM, RhysEvans P, et al. Making sense of post-treatment surveillance in head and neck cancer: when and what of follow-up. Cancer Treat Rev. 2009; Dec. 35(8):744–53.

443. Piazza C, Del Bon F, Peretti G, Nicolai P. Narrow band imaging in endoscopic evaluation of the larynx. Curr Opin Otolaryngol Head Neck Surg. 2012; Dec. 20(6):472–6.

444. Piazza C. Is narrow band imaging the ideal screening tool for mucosal head and neck cancer? Oral Oncol. 2011; May. 47(5):313.

445. Piazza C, Cocco D, De Benedetto L, Del Bon F, Nicolai P, Peretti G. Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients. Eur Arch Otorhinolaryngol. 2010; Mar. 267(3):409–14.

446. Gold KA, Kim ES. Role of molecular markers and gene profiling in head and neck cancers. Curr Opin Oncol. 2009; May. 21(3):206–11.

447. Braakhuis BJ, Brakenhoff RH, Leemans CR. Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg. 2010; Apr. 18(2):67–71.

448. Tell R, Sjodin H, Lundell G, Lewin F, Lewensohn R. Hypothyroidism after external radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys. 1997; Sep. 39(2):303–8.

449. Leon X, Gras JR, Perez A, Rodriguez J, de Andres L, Orus C, et al. Hypothyroidism in patients treated with total laryngectomy: a multivariate study. Eur Arch Otorhinolaryngol. 2002; Apr. 259(4):193–6.

450. Sinard RJ, Tobin EJ, Mazzaferri EL, Hodgson SE, Young DC, Kunz AL, et al. Hypothyroidism after treatment for nonthyroid head and neck cancer. Arch Otolaryngol Head Neck Surg. 2000; May. 126(5):652–7.

451. Biel MA, Maisel RH. Indications for performing hemithyroidectomy for tumors requiring total laryngectomy. Am J Surg. 1985; Oct. 150(4):435–9.

452. Alkan S, Baylancicek S, Ciftcic M, Sozen E, Dadas B. Thyroid dysfunction after combined therapy for laryngeal cancer: a prospective study. Otolaryngol Head Neck Surg. 2008; Dec. 139(6):787–91.

453. Posner MR, Ervin TJ, Miller D, Fabian RL, Norris CM Jr, Weichselbaum RR, et al. Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck. Laryngoscope. 1984; Apr. 94(4):451–54.

454. Ho AC, Ho WK, Lam PK, Yuen AP, Wei WI. Thyroid dysfunction in laryngectomees-10 years after treatment. Head Neck. 2008; Mar. 30(3):336–40.

455. Brandenburg JH, Rutter SW. Residual carcinoma of the larynx. Laryngoscope. 1977; Feb. 87(2):224–36.

456. Johansen LV, Grau C, Overgaard J. Glottic carcinoma: patterns of failure and salvage treatment after curative radiotherapy in 861 consecutive patients. Radiother Oncol. 2002; Jun. 63(3):257–67.

457. Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys. 2002; Jul. 53(4):948–58.

458. Harada A, Sasaki R, Miyawaki D, Yoshida K, Nishimura H, Ejima Y, et al. Treatment outcomes of the patients with early glottic cancer treated with initial radiotherapy and salvaged by conservative surgery. Jpn J Clin Oncol. 2015; Mar. 45(3):248–55.

459. Mercante G, Bacciu A, Banchini L, Moretto E, Oretti G, Ferri T. Salvage surgery after radiation failure in squamous cell carcinoma of the larynx. B-ENT. 2005; 1(3):107–11.

460. McLaughlin MP, Parsons JT, Fein DA, Stringer SP, Cassisi NJ, Mendenhall WM, et al. Salvage surgery after radiotherapy failure in T1- T2 squamous cell carcinoma of the glottic larynx. Head Neck. 1996; May-Jun. 18(3):229–35.

461. Virtaniemi JA, Hirvikoski PP, Kumpulainen EJ, Johansson RT, Kosma VM. Surgical management of irradiation failures in T1-T2 squamous cell carcinoma of the glottic larynx. Anticancer Res. 2001; Nov-Dec. 21(6A):4185–8.

462. Furusaka T, Susaki Y, Saito T, Katsura Y, Ikeda M. Long-term followup and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottis larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation. Acta Otolaryngol. 2013; Jan. 133(1):91–8.

463. Weber RS, Berkey BA, Forastiere A, Cooper J, Maor M, Goepfert H, et al. Outcome of salvage total laryngectomy following organ preservation therapy: the Radiation Therapy Oncology Group trial 91-11. Arch Otolaryngol Head Neck Surg. 2003; Jan. 129(1):44–9.

464. Stoeckli SJ, Pawlik AB, Lipp M, Huber A, Schmid S. Salvage surgery after failure of nonsurgical therapy for carcinoma of the larynx and hypopharynx. Arch Otolaryngol Head Neck Surg. 2000; Dec. 126(12):1473–7.

465. Santoro R, Meccariello G, Mannelli G, Bini B, Paiar F, Gallo O. Surgical options in radiotherapy-failed early glottic cancer. Eur Arch Otorhinolaryngol. 2014; Apr. 271(4):777–85.

466. Wilson KM. The status of partial salvage laryngeal surgery following definitive primary radiotherapy. Curr Opin Otolaryngol Head Neck Surg. 2000; Apr. 8(2):103–6.

467. Rodriguez-Cuevas S, Labastida S, Gonzalez D, Briseno N, Cortes H. Partial laryngectomy as salvage surgery for radiation failures in T1-T2 laryngeal cancer. Head Neck. 1998; Oct. 20(7):630–3.

468. Clark J, Morgan G, Veness M, Dalton C, Kalnins I. Salvage with supracricoid partial laryngectomy after radiation failure. ANZ J Surg. 2005; Nov. 75(11):958–62.

469. Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, et al. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg. 2006; Jan. 132(1):59–66.

470. Holsinger FC, Funk E, Roberts DB, Diaz EM Jr. Conservation laryngeal surgery versus total laryngectomy for radiation failure in laryngeal cancer. Head Neck. 2006; Sep. 28(9):779–84.

471. Mooney WW, Cole I, Albsoul N, Pearson SA. Salvage vertical partial laryngectomy for radiation failure in early glottic carcinoma. ANZ J Surg. 2002; Oct. 72(10):746–9.

472. Croll GA, van den Broek P, Tiwari RM, Manni JJ, Snow GB. Vertical partial laryngectomy for recurrent glottic carcinoma after irradiation. Head Neck Surg. 1985; May-Jun. 7(5):390–3.

473. Motamed M, Laccourreye O, Bradley PJ. Salvage conservation laryngeal surgery after irradiation failure for early laryngeal cancer. Laryngoscope. 2006; Mar. 116(3):451–5.

474. Barbu AM, Burns JA, Lopez-Guerra G, Landau-Zemer T, Friedman AD, Zeitels SM. Salvage endoscopic angiolytic KTP laser treatment of early glottic cancer after failed radiotherapy. Ann Otol Rhinol Laryngol. 2013; Apr. 122(4):235–9.

475. Laccourreye O, Weinstein G, Naudo P, Cauchois R, Laccourreye H, Brasnu D. Supracricoid partial laryngectomy after failed laryngeal radiation therapy. Laryngoscope. 1996; Apr. 106(4):495–8.

476. Sewnaik A, Meeuwis CA, van der Kwast TH, Kerrebijn JD. Partial laryngectomy for recurrent glottic carcinoma after radiotherapy. Head Neck. 2005; Feb. 27(2):101–7.

477. Chen MM, Holsinger FC, Laccourreye O. Salvage conservation laryngeal surgery after radiation therapy failure. Otolaryngol Clin North Am. 2015; Aug. 48(4):667–75.

478. Marioni G, Marchese-Ragona R, Kleinsasser NH, Lionello M, Lawson G, Hagen R, et al. Partial laryngeal surgery in recurrent carcinoma. Acta Otolaryngol. 2015; Feb. 135(2):119–24.

479. Marioni G, Marchese-Ragona R, Pastore A, Staffieri A. The role of supracricoid laryngectomy for glottic carcinoma recurrence after radiotherapy failure: a critical review. Acta Otolaryngol. 2006; Dec. 126(12):1245–51.

480. Marioni G, Marchese-Ragona R, Lucioni M, Staffieri A. Organ-preservation surgery following failed radiotherapy for laryngeal cancer. Evaluation, patient selection, functional outcome and survival. Curr Opin Otolaryngol Head Neck Surg. 2008; Apr. 16(2):141–6.

481. de Gier HH, Knegt PP, de Boer MF, Meeuwis CA, van der Velden LA, Kerrebijn JD. CO2-laser treatment of recurrent glottic carcinoma. Head Neck. 2001; Mar. 23(3):177–80.

482. Han YJ, Lee HS, Kim SW, Hong JC, Kim ST, Park HS, et al. Transoral laser microsurgery of recurrent early glottic cancer after radiation therapy: clinical feasibility and limitations. Ann Otol Rhinol Laryngol. 2012; Jun. 121(6):375–82.

483. Huang J, Yu Z, Fang J, Chen X, Chen X, Huang Z. Salvage transoral laser microsurgery for early recurrent glottic carcinoma after primary laser treatment. Acta Otolaryngol. 2013; May. 133(5):531–7.

484. Roedel RM, Matthias C, Wolff HA, Schindler P, Aydin T, Christiansen H. Transoral laser microsurgery for recurrence after primary radiotherapy of early glottic cancer. Auris Nasus Larynx. 2010; Aug. 37(4):474–81.

485. Steiner W, Vogt P, Ambrosch P, Kron M. Transoral carbon dioxide laser microsurgery for recurrent glottic carcinoma after radiotherapy. Head Neck. 2004; Jun. 26(6):477–84.

486. Ganly I, Patel S, Matsuo J, Singh B, Kraus D, Boyle J, et al. Postoperative complications of salvage total laryngectomy. Cancer. 2005; May. 103(10):2073–81.

487. Sewnaik A, Keereweer S, Al-Mamgani A, Baatenburg de Jong RJ, Wieringa MH, Meeuwis CA, et al. High complication risk of salvage surgery after chemoradiation failures. Acta Otolaryngol. 2012; Jan. 132(1):96–100.

488. Furuta Y, Homma A, Oridate N, Suzuki F, Hatakeyama H, Suzuki K, et al. Surgical complications of salvage total laryngectomy following concurrent chemoradiotherapy. Int J Clin Oncol. 2008; Dec. 13(6):521–7.

489. Scotton WJ, Nixon IJ, Pezier TF, Cobb R, Joshi A, Urbano TG, et al. Time interval between primary radiotherapy and salvage laryngectomy: a predictor of pharyngocutaneous fistula formation. Eur Arch Otorhinolaryngol. 2014; Aug. 271(8):2277–83.

490. Fung K, Teknos TN, Vandenberg CD, Lyden TH, Bradford CR, Hogikyan ND, et al. Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head Neck. 2007; May. 29(5):425–30.

491. Gil Z, Gupta A, Kummer B, Cordeiro PG, Kraus DH, Shah JP, et al. The role of pectoralis major muscle flap in salvage total laryngectomy. Arch Otolaryngol Head Neck Surg. 2009; Oct. 135(10):1019–23.

492. Gilbert MR, Sturm JJ, Gooding WE, Johnson JT, Kim S. Pectoralis major myofascial onlay and myocutaneous flaps and pharyngocutaneous fistula in salvage laryngectomy. Laryngoscope. 2014; Dec. 124(12):2680–6.

493. Guimaraes AV, Aires FT, Dedivitis RA, Kulcsar MA, Ramos DM, Cernea CR, et al. Efficacy of pectoralis major muscle flap for pharyngocutaneous fistula prevention in salvage total laryngectomy: a systematic review. Head Neck. 2016; Apr. 38 Suppl 1:E2317–21.

494. Oosthuizen JC, Leonard DS, Kinsella JB. The role of pectoralis major myofascial flap in salvage laryngectomy: a single surgeon experience. Acta Otolaryngol. 2012; Sep. 132(9):1002–5.

495. Patel UA, Moore BA, Wax M, Rosenthal E, Sweeny L, Militsakh ON, et al. Impact of pharyngeal closure technique on fistula after salvage laryngectomy. JAMA Otolaryngol Head Neck Surg. 2013; Nov. 139(11):1156–62.

496. Sousa AA, Castro SM, Porcaro-Salles JM, Soares JM, de Moraes GM, Carvalho JR, et al. The usefulness of a pectoralis major myocutaneous flap in preventing salivary fistulae after salvage total laryngectomy. Braz J Otorhinolaryngol. 2012; Jul-Aug. 78(4):103–7.

497. Withrow KP, Rosenthal EL, Gourin CG, Peters GE, Magnuson JS, Terris DJ, et al. Free tissue transfer to manage salvage laryngectomy defects after organ preservation failure. Laryngoscope. 2007; May. 117(5):781–4.

498. Jeong WJ, Jung YH, Kwon SK, Hah JH, Kwon TK, Sung MW, et al. Role of surgical salvage for regional recurrence in laryngeal cancer. Laryngoscope. 2007; Jan. 117(1):74–7.

499. Koss SL, Russell MD, Leem TH, Schiff BA, Smith RV. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage. Laryngoscope. 2014; Feb. 124(2):421–8.

500. Pennings RJ, Marres HA, den Heeten A, van den Hoogen FJ. Efficacy of diagnostic upper node evaluation during (salvage) laryngectomy for supraglottic carcinoma. Head Neck. 2009; Feb. 31(2):158–66.

501. Hilly O, Gil Z, Goldhaber D, Amit M, Biadsee A, Popovtzer A, et al. Elective neck dissection during salvage total laryngectomy: a beneficial prognostic effect in locally advanced recurrent tumours. Clin Otolaryngol. 2015; Feb. 40(1):9–15.

502. Yao M, Roebuck JC, Holsinger FC, Myers JN. Elective neck dissection during salvage laryngectomy. Am J Otolaryngol. 2005; NovDec. 26(6):388–92.

503. Amit M, Hilly O, Leider-Trejo L, Popovtzer A, Gutfeld O, Shvero J, et al. The role of elective neck dissection in patients undergoing salvage laryngectomy. Head Neck. 2013; Oct. 35(10):1392–6.

504. Wax MK, Touma BJ. Management of the N0 neck during salvage laryngectomy. Laryngoscope. 1999; Jan. 109(1):4–7.

505. Bohannon IA, Desmond RA, Clemons L, Magnuson JS, Carroll WR, Rosenthal EL. Management of the N0 neck in recurrent laryngeal squamous cell carcinoma. Laryngoscope. 2010; Jan. 120(1):58–61.

506. Deganello A, Meccariello G, Bini B, Paiar F, Santoro R, Mannelli G, et al. Is elective neck dissection necessary in cases of laryngeal recurrence after previous radiotherapy for early glottic cancer? J Laryngol Otol. 2014; Dec. 128(12):1089–94.

507. Basheeth N, O’Leary G, Sheahan P. Elective neck dissection for no neck during salvage total laryngectomy: findings, complications, and oncological outcome. JAMA Otolaryngol Head Neck Surg. 2013; Aug. 139(8):790–6.

508. Farrag TY, Lin FR, Cummings CW, Koch WM, Flint PW, Califano JA, et al. Neck management in patients undergoing postradiotherapy salvage laryngeal surgery for recurrent/persistent laryngeal cancer. Laryngoscope. 2006; Oct. 116(10):1864–6.

509. Sanabria A, Silver CE, Olsen KD, Medina JE, Hamoir M, Paleri V, et al. Is elective neck dissection indicated during salvage surgery for head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2014; Dec. 271(12):3111–9.

510. Mortuaire G, Francois J, Wiel E, Chevalier D. Local recurrence after CO2 laser cordectomy for early glottic carcinoma. Laryngoscope. 2006; Jan. 116(1):101–5.

511. Roedel RM, Matthias C, Wolff HA, Christiansen H. Repeated transoral laser microsurgery for early and advanced recurrence of early glottic cancer after primary laser resection. Auris Nasus Larynx. 2010; Jun. 37(3):340–6.

512. Yuen AP, Ho CM, Wei WI, Lam LK. Prognosis of recurrent laryngeal carcinoma after laryngectomy. Head Neck. 1995; Nov-Dec. 17(6):526–30.

513. Ritoe SC, Bergman H, Krabbe PF, Kaanders JH, van den Hoogen FJ, Verbeek AL, et al. Cancer recurrence after total laryngectomy: treatment options, survival, and complications. Head Neck. 2006; May. 28(5):383–8.

514. Ampil F, Ghali G, Caldito G, Baluna R. Post-laryngectomy stomal cancer recurrences, re-treatment decisions and outcomes: case series. J Craniomaxillofac Surg. 2009; Sep. 37(6):349–51.

515. Buckley JG. Tracheostomal recurrence after laryngectomy. CME Bull Otorhinolaryngol Head Neck Surg. 2000; Jan. 4(3):100–5.

516. Gluckman JL, Hamaker RC, Schuller DE, Weissler MC, Charles GA. Surgical salvage for stomal recurrence: a multi-institutional experience. Laryngoscope. 1987; Sep. 97(9):1025–9.

517. Udaipurwala IH, Iqbal K, Jalisi M. Stomal recurrence after total laryngectomy. J Pak Med Assoc. 1996; Jul. 46(7):154–6.

518. Esteller E, Aguero A, Martel M, Lopez M, Quer M, Leon X. Stomal recurrence in head and neck cancer patients with temporary tracheostomy. Auris Nasus Larynx. 2014; Oct. 41(5):467–70.

519. Hassanabadi MS, Shadabi S, Sadr-Hosseini SM, Zarandi MM, Eghtesadi-Araghi P. Assessment of the recurrence rate of laryngeal cancer in tracheostoma in patient undergoing laryngectomy. J Med Sci. 2007; 7(4):630–4.

520. Sartini AL, Fava AS, de Faria PH. Surgical stoma recurrence after total laringectomy. Braz J Otorhinolaryngol. 2007; Jan-Feb. 73(1):80–6.

521. Yuen AP, Wei WI, Ho WK, Hui Y. Risk factors of tracheostomal recurrence after laryngectomy for laryngeal carcinoma. Am J Surg. 1996; Sep. 172(3):263–6.

522. Bignardi L, Gavioli C, Staffieri A. Tracheostomal recurrences after laryngectomy. Arch Otorhinolaryngol. 1983; 238(2):107–13.

523. Bonneau RA, Lehman RH. Stomal recurrence following laryngectomy. Arch Otolaryngol. 1975; Jul. 101(7):408–12.

524. Esteban F, Moreno JA, Delgado-Rodriguez M, Mochon A. Risk factors involved in stomal recurrence following laryngectomy. J Laryngol Otol. 1993; Jun. 107(6):527–31.

525. Leon X, Quer M, Burgues J, Abello P, Vega M, de Andres L. Prevention of stomal recurrence. Head Neck. 1996; Jan-Feb. 18(1):54–9.

526. Imauchi Y, Ito K, Takasago E, Nibu K, Sugasawa M, Ichimura K. Stomal recurrence after total laryngectomy for squamous cell carcinoma of the larynx. Otolaryngol Head Neck Surg. 2002; Jan. 126(1):63–6.

527. Rockley TJ, Powell J, Robin PE, Reid AP. Post-laryngectomy stomal recurrence: tumour implantation or paratracheal lymphatic metastasis. Clin Otolaryngol Allied Sci. 1991; Feb. 16(1):43–7.

528. Santoro R, Franchi A, Tempesti C, Sardi I, Polli G. Stomal recurrence following total laryngectomy: clinical and molecular analysis of a series. Ann Otol Rhinol Laryngol. 2003; Jul. 112(7):594–9.

529. Yotakis J, Davris S, Kontozoglou T, Adamopoulos G. Evaluation of risk factors for stomal recurrence after total laryngectomy. Clin Otolaryngol Allied Sci. 1996; Apr. 21(2):135–8.

530. Zbaren P, Greiner R, Kengelbacher M. Stoma recurrence after laryngectomy: an analysis of risk factors. Otolaryngol Head Neck Surg. 1996; Apr. 114(4):569–75.

531. Zhao H, Ren J, Zhuo X, Ye H, Zou J, Liu S. Stomal recurrence after total laryngectomy: a clinicopathological multivariate analysis. Am J Clin Oncol. 2009; Apr. 32(2):154–7.

532. Pezier TF, Nixon IJ, Joshi A, Pang L, Guerrero-Urbano T, Oakley R, et al. Pre-operative tracheostomy does not impact on stomal recurrence and overall survival in patients undergoing primary laryngectomy. Eur Arch Otorhinolaryngol. 2013; May. 270(5):1729–35.

533. Fagan JJ, Loock JW. Tracheostomy and peristomal recurrence. Clin Otolaryngol Allied Sci. 1996; Aug. 21(4):328–30.